image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
1878b9c55e29f73e0ea05c8b5b21f2577c0dc2139a458583c7edcf652e0cf1e9.png | simple | <table><tr><td><i>Regression parameter</i></td><td><i>Slope (a)</i></td><td><i>Intercept (b)</i></td><td><i>Data point count</i></td><td><i>R<sup>2</sup></i></td></tr><tr><td>value</td><td>1.09</td><td>0.03</td><td>679</td><td>0.98</td></tr></table> | <table><tr><td>Regression parameter</td><td>Slope (a)</td><td>Intercept (b)</td><td>Data point count</td><td>R2</td></tr><tr><td>value</td><td>1.09</td><td>0.03</td><td></td><td>0</td></tr></table> | <table><tr><td></td><td></td><td></td><td>679</td><td>.98</td></tr></table> |
45cee9d364298a017be7904f867e751a0b16811e31cee8d1a9e5e2f2a3765e83.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">CA125 (U/ml)</td><td colspan="2">HE4 (pmol/l)</td><td colspan="2">ROMA (%)</td><td colspan="2">ROMA P (%)</td><td rowspan="2">p (ROMA vs. ROMA P)</td></tr><tr><td>Median</td><td>Range</td><td>Median</td><td>Range</td><td>Median</td><td>Range</td><td>Median</td><td>Range</... | <table><tr><td rowspan="2"></td><td colspan="2">CA125 (U/ml)</td><td colspan="2">HE4 (pmol/l)</td><td colspan="2">ROMA (%)</td><td colspan="2">ROMA P (%)</td><td rowspan="2">p (ROMA vs. ROMA P)</td></tr><tr><td>Median</td><td>Range</td><td>Median</td><td>Range</td><td>Median</td><td>Range</td><td>Median</td><td>Range</... | <table><tr><td>W7 ovarian cancer group</td><td>839</td><td>21–5659</td><td>658.4</td><td>37–8160</td><td>97</td><td>25–100</td><td>97.2</td><td>23.8–99.9</td><td>0.7710</td></tr><tr><td>W8 ovarian cancer group</td><td>777.5</td><td>66.9–3724</td><td>871.2</td><td>85.8–4940</td><td>97.7</td><td>55.1–100</td><td>97.9</td... |
d1b16036854970122f03e5c907eefb06510bd0f7a5f9babb7776f9a9d3dc1d4e.png | complex | <table><tr><td rowspan="2">Genogroup rate used</td><td rowspan="2">Segregation</td><td rowspan="2">Time (yr) since divergence<sup><i>a</i></sup></td><td colspan="2">95% CI<sup><i>b</i></sup></td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td>5B and 5A</td><td>5A and 5B</td><td>7.14</td><td>1.71</td><td>28.36</td></t... | <table><tr><td rowspan="2">Genogroup rate used</td><td rowspan="2">Segregation</td></tr><tr></tr><tr><td>5B and 5A</td><td>5A and 5B</td></tr><tr><td></td><td>5B and Bandim 6</td></tr><tr><td></td><td>5B and Bandim 13/14</td></tr><tr><td>5B only</td><td>5A and 5B</td></tr><tr><td></td><td>5B and Bandim 6</td></tr><tr><... | <table><tr><td rowspan="2">Time (yr) since divergencea</td><td colspan="2">95% CIb</td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td>7.14</td><td>1.71</td><td>28.36</td></tr><tr><td>3.47</td><td>0.86</td><td>13.70</td></tr><tr><td>2.00</td><td>0.53</td><td>7.91</td></tr><tr><td>2.29</td><td>1.68</td><td>2.95</td></... |
d7a18b2391ef5f620d7f7cb41c84d03475a0249b664e673bfadf43f2258bd82a.png | complex | <table><tr><td rowspan="2">Month</td><td colspan="3">2008</td><td colspan="3">2009</td><td colspan="3">2010</td><td colspan="3">2011</td><td colspan="3">2012</td></tr><tr><td>Total</td><td colspan="2">Positive</td><td>Total</td><td colspan="2">Positive</td><td>Total</td><td colspan="2">Positive</td><td>Total</td><td co... | <table><tr><td rowspan="2">Month</td><td colspan="3">2008</td></tr><tr><td>Total</td><td colspan="2">Positive</td></tr><tr><td></td><td></td><td>n</td><td>%</td></tr><tr><td>January</td><td>10</td><td>6</td><td>60</td></tr><tr><td>February</td><td>16</td><td>3</td><td>19</td></tr><tr><td>March</td><td>18</td><td>5</td>... | <table><tr><td colspan="3">2009</td><td colspan="3">2010</td><td colspan="3">2011</td><td colspan="3">2012</td></tr><tr><td>Total</td><td colspan="2">Positive</td><td>Total</td><td colspan="2">Positive</td><td>Total</td><td colspan="2">Positive</td><td>Total</td><td colspan="2">Positive</td></tr><tr><td></td><td>n</td>... |
cbb629d62ce516ca336071caa9b2d66994e2f902b85b629d5eaf666707b6a10f.png | complex | <table><tr><td></td><td></td><td colspan="2">Baseline</td><td colspan="2">Postexposure</td><td></td></tr><tr><td>Outcome</td><td><i>n</i>a</td><td>Mean ± SD</td><td>Range</td><td>Mean ± SD</td><td>Range</td><td><i>p</i>-Value</td></tr><tr><td>White blood cells (10<sup>3</sup>/mm<sup>3</sup>)</td><td>62</td><t... | <table><tr><td></td><td></td></tr><tr><td>Outcome</td><td>na</td></tr><tr><td>White blood cells (103/mm3)</td><td>62</td></tr><tr><td>Granulocytes (%)</td><td>62</td></tr><tr><td>Lymphocytes (%)</td><td>62</td></tr><tr><td>Monocytes (%)</td><td>62</td></tr><tr><td>LTL (T/S ratio)</td><td>57</td></tr><tr><td>hTERT expre... | <table><tr><td colspan="2">Baseline</td><td colspan="2">Postexposure</td><td></td></tr><tr><td>Mean ± SD</td><td>Range</td><td>Mean ± SD</td><td>Range</td><td>p-Value</td></tr><tr><td>7.31 ± 1.6</td><td>3.6–10.4</td><td>7.3 ± 1.7</td><td>4.0–13.0</td><td>0.91</td></tr><tr><td>58.9 ± 7.2</td><td>43.5–76.0</td><td>58.2 ±... |
80cff1cf4bc92b53494176570db388f7b88fedd163ed39b3e987c9dfd837b9ab.png | simple | <table><tr><td>Matrix</td><td>Filler</td><td>Code name</td></tr><tr><td>PP-SL262MW</td><td>–</td><td>PP</td></tr><tr><td>PP-SL262MW</td><td>Sol-gel (catalyst: acetic acid)</td><td>PP-Acetic</td></tr><tr><td>PP-SL262MW</td><td>Sol-gel (catalyst: formic acid)</td><td>PP-Formic</td></tr><tr><td>PP-SL262MW</td><td>So... | <table><tr><td>Matrix</td><td>Filler</td><td>Code name</td></tr><tr><td>PP-SL262MW</td><td>–</td><td>PP</td></tr><tr><td>PP-SL262MW</td><td>Sol-gel (catalyst: acetic acid)</td><td>PP-Acetic</td></tr><tr><td>PP-SL262MW</td><td>Sol-gel (catalyst: formic acid)</td><td>PP-Formic</td></tr><tr><td>PP-SL262MW</td><td>Sol-gel ... | <table><tr><td>Matrix</td><td>Filler</td><td>Code name</td></tr><tr><td>PP-SL262MW</td><td>Functionalized CNT</td><td>PP-CNTF</td></tr></table> |
6e0125d2a9c82a53f16e169973a532ff54ebd10dd072a36a0fba8f4cb78cf641.png | complex | <table><tr><td>Factors</td><td>Domain</td><td>Data collected</td><td>Sources of information</td></tr><tr><td rowspan="2">Technical factors</td><td rowspan="2">Reporting system</td><td>Type of new tools introduced by the NTCP and their use</td><td>Interviews</td></tr><tr><td>Availability of tuberculosis and routine info... | <table><tr><td>Factors</td><td>Domain</td><td>Data collected</td><td>Sources of information</td></tr><tr><td rowspan="2">Technical factors</td><td rowspan="2">Reporting system</td><td>Type of new tools introduced by the NTCP and their use</td><td>Interviews</td></tr><tr><td>Availability of tuberculosis and routine info... | <table><tr><td rowspan="2"></td><td rowspan="2">rvision</td><td>equency)</td><td rowspan="2">servation</td></tr><tr><td>Staff members supervised in the use of the routine HIS (frequency)</td></tr><tr><td></td><td>Training</td><td>Training received on HIS management: trainees and date</td><td>Interviews</td></tr><tr><td... |
dfee5b92d7f9be53a280d45225d19eea9a5517b037ac00e34b9e5a6300964514.png | simple | <table><tr><td>Variables</td><td>Average</td><td>Minimum</td><td>Maximum</td></tr><tr><td>Herd size</td><td>100</td><td>40</td><td>220</td></tr><tr><td>Milk production (kg/herd/year)</td><td>815,429</td><td>340,000</td><td>1,850,000</td></tr><tr><td>Milk production (kg/cow/year)</td><td>8,174</td><td>5,333</td><td>10,4... | <table><tr><td>Variables</td><td>Average</td><td>Minimum</td><td>Maximum</td></tr><tr><td>Herd size</td><td>100</td><td>40</td><td>220</td></tr><tr><td>Milk production (kg/herd/year)</td><td>815,429</td><td>340,000</td><td>1,850,000</td></tr><tr><td>Milk production (kg/cow/year)</td><td>8,174</td><td>5,333</td><td>10,4... | <table><tr><td>Variables</td><td>Average</td><td>Minimum</td><td>Maximum</td></tr><tr><td>Number of present young stock per year</td><td>69</td><td>19</td><td>152</td></tr></table> |
872a260d991d96aa10ac5e1bdb8f193745a90ddfe28bde49775941c2d8742d3c.png | complex | <table><tr><td rowspan="2">Parameter</td><td colspan="3">% found</td></tr><tr><td>Tb<sup>+3</sup></td><td>La<sup>+3</sup></td><td>Ce<sup>+3</sup></td></tr><tr><td>Alkaline degradation FMT added = 20ng/ml</td><td></td><td></td><td></td></tr><tr><td><overline>X</overline>±SD</td><td>100.68 ± 0.87</td><td>100.18... | <table><tr><td rowspan="2">Parameter</td><td colspan="3">% found</td></tr><tr><td>Tb+3</td><td>La+3</td><td>Ce+3</td></tr><tr><td>Alkaline degradation FMT added = 20ng/ml</td><td></td><td></td><td></td></tr><tr><td>X±SD</td><td>100.68 ± 0.87</td><td>100.18 ± 0.59</td><td>100.10 ± 0.58</td></tr><tr><td>Student’s t test<... | <table><tr><td>Variance ratio F test</td><td>1.97 (6.94)</td><td>1.10 (6.94)</td><td>1.14 (6.94)</td></tr><tr><td>Alkaline degradation FMT added= 40ng/ml</td><td></td><td></td><td></td></tr><tr><td>X±SD</td><td>100.08 ± 0.84</td><td>99.99 ± 0.50</td><td>100.15 ± 0.46</td></tr><tr><td>Student’s t test</td><td>0.84 (2.78... |
23d8cf6cf282bbac7cf54b596fd6602373fc89c707c8f383b595559d6ac9157c.png | complex | <table><tr><td rowspan="3"></td><td rowspan="3"><i>J</i> Inertia (Kg/m<sup>2</sup>)</td><td rowspan="3"><i>R</i> Resister (Ohm)</td><td colspan="2"><i>K<sub>t</sub></i> Torque constant (Nm/A)</td><td colspan="2"><i>K<sub>m</sub></i> Restoring constant (Nm/rad)</td></tr><tr><td>Simulation</td><td>Experiment</td><td>Simu... | <table><tr><td rowspan="3"></td><td rowspan="3">J Inertia (Kg/m2)</td><td rowspan="3">R Resister (Ohm)</td><td colspan="2">Kt Torque constant (Nm/A)</td><td colspan="2">Km Restoring constant (Nm/rad)</td></tr><tr><td>Simulation</td><td>Experiment</td><td>Simulation</td><td>Experiment</td></tr><tr><td colspan="4"></td><... | <table><tr><td>Y-axis</td><td>55.65e-9</td><td>145</td><td>2.14e-2</td><td>2.17e-2</td><td>7.07e-3</td><td>6.28e-3</td></tr></table> |
e4f4cb7a31570868c616987552e617a4cebbbc55ffba9ae84d7c36c45981d417.png | complex | <table><tr><td rowspan="3">Variable</td><td colspan="2">HBV status</td><td rowspan="3"><i>P</i>-value</td></tr><tr><td>Positive</td><td>Negative</td></tr><tr><td>(N = 29)</td><td>(N = 171)</td></tr><tr><td><i>Age group</i></td><td></td><td></td><td>0.211</td></tr><tr><td> <20</td><td>1 (3.4)</td><td>10 (5.8)</td><td... | <table><tr><td rowspan="3">Variable</td><td colspan="2">HBV status</td><td rowspan="3">P-value</td></tr><tr><td>Positive</td><td>Negative</td></tr><tr><td>(N = 29)</td><td>(N = 171)</td></tr><tr><td>Age group</td><td></td><td></td><td>0.211</td></tr><tr><td><20</td><td>1 (3.4)</td><td>10 (5.8)</td><td></td></tr><tr><td... | <table><tr><td colspan="2">Ever had unprotected sex before?</td><td></td><td>0.779</td></tr><tr><td>Yes</td><td>24 (82.8)</td><td>145 (84.8)</td><td></td></tr><tr><td>No</td><td>5 (17.2)</td><td>26 (15.2)</td><td></td></tr><tr><td>Vaccinated for Hepatitis B</td><td></td><td></td><td>0.182</td></tr><tr><td>Yes</td><td>0... |
fdc1dcdea2a64e88bc579be1fb3e8793dc0bd87aae7241023a327a8d8ddcbda7.png | complex | <table><tr><td rowspan="3"></td><td rowspan="2" colspan="2">All</td><td colspan="6">SUDOSCAN Risk Score</td><td><i>p</i></td></tr><tr><td colspan="2">No Risk</td><td colspan="2">Moderate Risk</td><td colspan="2">Elevated Risk</td><td></td></tr><tr><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td>... | <table><tr><td rowspan="3"></td><td rowspan="2" colspan="2">All</td><td colspan="6">SUDOSCAN Risk Score</td><td>p</td></tr><tr><td colspan="2">No Risk</td><td colspan="2">Moderate Risk</td><td colspan="2">Elevated Risk</td><td></td></tr><tr><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mea... | <table><tr><td>Weight (kg)</td><td>69.7</td><td>12.9</td><td>63.5</td><td>8.7</td><td>66.9</td><td>9.5</td><td>77.9</td><td>14.7</td><td><0.0001</td></tr><tr><td>Waist (cm)</td><td>88.6</td><td>12.2</td><td>81.3</td><td>8.5</td><td>86.6</td><td>9.1</td><td>96.7</td><td>12.9</td><td><0.0001</td></tr><tr><td>Body fat (%)... |
b53e01d21e015e326240feac6921a3564d71f12d5ab177f5cc9e1197ee38c9ab.png | simple | <table><tr><td>Characteristics</td><td>Feminized Male CRC (Total = 26) No. (%)</td><td>Non-Feminized Male CRC (Total = 31) No. (%)</td><td>Total Males (Total = 57) No. (%)</td><td><i>p</i>-Value</td></tr><tr><td>MSS—wild type <i>BRAF</i></td><td>24 (92.3)</td><td>17 (56.7)</td><td>41 (72.0)</td><td>0.0026 *</td><... | <table><tr><td>Characteristics</td><td>Feminized Male CRC (Total = 26) No. (%)</td><td>Non-Feminized Male CRC (Total = 31) No. (%)</td><td>Total Males (Total = 57) No. (%)</td><td>p-Value</td></tr></table> | <table><tr><td>MSS—wild type BRAF</td><td>24 (92.3)</td><td>17 (56.7)</td><td>41 (72.0)</td><td>0.0026 *</td></tr><tr><td>Wild-type BRAF</td><td>26 (100)</td><td>23 (74.2)</td><td>49 (86.0)</td><td>0.0088 *</td></tr><tr><td>MMR proficient</td><td>24 (92.3)</td><td>19 (61.2)</td><td>43 (75.4)</td><td>0.0107 *</td></tr><... |
98871f9516062c6a63158e51c0bc095827730a0bc2263855533d2a250158384e.png | complex | <table><tr><td></td><td></td><td></td><td></td><td></td><td></td><td colspan="2">Prior Probability of Mutation in a <i>BRCA </i>gene</td></tr><tr><td>Case #</td><td>Cancer diagnosis (index-case)</td><td>Age at diagnosis (ys)</td><td>Cancer family history*</td><td>ASCO criteria</td><td>Limited Family Structure</td><td>M... | <table><tr><td></td><td></td><td></td><td></td><td></td><td></td><td colspan="2">Prior Probability of Mutation in a BRCA gene</td></tr><tr><td>Case #</td><td>Cancer diagnosis (index-case)</td><td>Age at diagnosis (ys)</td><td>Cancer family history*</td><td>ASCO criteria</td><td>Limited Family Structure</td><td>Myriad P... | <table><tr><td></td><td></td><td></td><td></td><td></td><td></td><td colspan="2">Prior Probability of Mutation in a BRCA gene</td></tr><tr><td>Case #</td><td>Cancer diagnosis (index-case)</td><td>Age at diagnosis (ys)</td><td>Cancer family history*</td><td>ASCO criteria</td><td>Limited Family Structure</td><td>Myriad P... |
b893fa89ec6536aee33d84420d37c161d1593ffade0d9a5e4f3aca9fae2d2eeb.png | simple | <table><tr><td>Oligo ID</td><td>Gene</td><td>Purpose</td><td>Sequences (5' to 3')</td></tr><tr><td>swcM1</td><td>M</td><td>capture</td><td>CTGACTAAGGGAATTTTAGGATTTGTGTTCACGCTCACCG</td></tr><tr><td>swcM2</td><td>M</td><td>capture</td><td>TGATTCACAGCATCGGTCTCACAGACAGATGGCTACTACC</td></tr><tr><td>swcM3</td><td>M</td><td>c... | <table><tr><td>Oligo ID</td><td>Gene</td><td>Purpose</td><td>Sequences (5' to 3')</td></tr><tr><td>swcM1</td><td>M</td><td>capture</td><td>CTGACTAAGGGAATTTTAGGATTTGTGTTCACGCTCACCG</td></tr><tr><td>swcM2</td><td>M</td><td>capture</td><td>TGATTCACAGCATCGGTCTCACAGACAGATGGCTACTACC</td></tr><tr><td>swcM3</td><td>M</td><td>c... | <table><tr><td>Oligo ID</td><td>Gene</td><td>Purpose</td><td>Sequences (5' to 3')</td></tr><tr><td>cN2</td><td>NA</td><td>re</td><td>TGCC</td></tr><tr><td>swcN3</td><td>NA</td><td>capture</td><td>CAATGGAACCATTAAAGACAGGAGCCCATATCGAACCCTA</td></tr><tr><td>swcN4</td><td>NA</td><td>capture</td><td>ACGCCCTAATGATAAGACAGGCAGT... |
093b4f2fd993b652f4384022d40477d90d0cfa6a2802bc57eaf61e523e1ef4f7.png | simple | <table><tr><td>Clinical guidelines directly related to the practice of dentistry</td><td>No.</td></tr><tr><td>American Dental Association</td><td>2</td></tr><tr><td>American Academy of Pediatric Dentistry</td><td>22</td></tr><tr><td>American Cleft Palate Craniofacial Association</td><td>1</td></tr><tr><td>American Acad... | <table><tr><td>Clinical guidelines directly related to the practice of dentistry</td><td>No.</td></tr><tr><td>American Dental Association</td><td>2</td></tr><tr><td>American Academy of Pediatric Dentistry</td><td>22</td></tr><tr><td>American Cleft Palate Craniofacial Association</td><td>1</td></tr><tr><td>American Acad... | <table><tr><td>Clinical guidelines directly related to the practice of dentistry</td><td>No.</td></tr><tr><td>US Preventive Services Task Force</td><td>2</td></tr><tr><td>New York State Department of Health</td><td>2</td></tr><tr><td>Health Partners</td><td>4</td></tr><tr><td>University of Texas at Austin</td><td>1</td... |
57816b4cfb393c133e9e7de03e34cb2d81469513a92181c5896cbd6907e2d305.png | simple | <table><tr><td>Age group</td><td>Outcome</td><td>Indicator</td><td>Measurement tool</td></tr><tr><td>Adults</td><td>Healthy eating*</td><td>Binary: consumption of five or more portions of fruit and vegetables per day (‘five-a-day’)</td><td>Food frequency questionnaire</td></tr><tr><td>Adults</td><td>Healthy... | <table><tr><td>Age group</td><td>Outcome</td><td>Indicator</td><td>Measurement tool</td></tr><tr><td>Adults</td><td>Healthy eating*</td><td>Binary: consumption of five or more portions of fruit and vegetables per day (‘five-a-day’)</td><td>Food frequency questionnaire</td></tr><tr><td>Adults</td><td>Healthy physical ac... | <table><tr><td>Adolescents</td><td>Healthy eating - positive</td><td>Binary: frequent consumption of fruit</td><td>Individual questionnaire item</td></tr><tr><td>Adolescents</td><td>Healthy eating negative</td><td>Continuous: score summarizing frequency of consumption of chips, sweets or chocolate, and s ugar sweetened... |
9ce17ec8d14671020c5bf71f4ad359d332a0b8d187b36ad5a348396c652f4a74.png | simple | <table><tr><td></td><td></td><td>Pre Meeting</td><td>Meeting</td><td>Test</td></tr><tr><td>Gender</td><td><i>Males</i></td><td>27</td><td>24</td><td>NS</td></tr><tr><td></td><td><i>Females</i></td><td>7</td><td>9</td><td></td></tr><tr><td>Age</td><td><i>(av +/- sd)</i></td><td>46.6 +/- 8.6</td><td>44.5 +/- 9.3</td><td>... | <table><tr><td></td><td></td><td>Pre Meeting</td><td>Meeting</td><td>Test</td></tr><tr><td>Gender</td><td>Males</td><td>27</td><td>24</td><td>NS</td></tr><tr><td></td><td>Females</td><td>7</td><td>9</td><td></td></tr><tr><td>Age</td><td>(av +/- sd)</td><td>46.6 +/- 8.6</td><td>44.5 +/- 9.3</td><td>NS</td></tr><tr><td>E... | <table><tr><td>ession</td><td>MD-OS</td><td>12</td><td></td><td></td></tr><tr><td></td><td>MD-PRM</td><td>6</td><td>9</td><td></td></tr><tr><td></td><td>CPO</td><td>5</td><td>8</td><td></td></tr><tr><td></td><td>PT</td><td>9</td><td>7</td><td></td></tr><tr><td></td><td>Oth</td><td>2</td><td>2</td><td></td></tr></table> |
192168c908cb0365115cdc2e72684481b825fec1067611f09c7da75c1febb68b.png | simple | <table><tr><td></td><td>PR n=15</td><td>GR n=15</td><td><i>p</i> Value</td></tr><tr><td>Age: mean (SD)</td><td>59.1 (7.2)</td><td>51.7 (10.8)</td><td>0.04*</td></tr><tr><td>Gender, number of patients: M (F)</td><td>10 (5)</td><td>8 (7)</td><td>0.46**</td></tr><tr><td>Time since stroke: mean (SD) and range (months)</td>... | <table><tr><td></td><td>PR n=15</td><td>GR n=15</td><td>p Value</td></tr><tr><td>Age: mean (SD)</td><td>59.1 (7.2)</td><td>51.7 (10.8)</td><td>0.04*</td></tr><tr><td>Gender, number of patients: M (F)</td><td>10 (5)</td><td>8 (7)</td><td>0.46**</td></tr><tr><td>Time since stroke: mean (SD) and range (months)</td><td>40.... | <table><tr><td>Grip mean: (SD) (% unaffected side)</td><td>41.4 (14.3)</td><td>74.6 (18.57)</td><td><0.01*</td></tr><tr><td>Motricity index: mean (SD) (% unaffected side)</td><td>65.2 (11.4)</td><td>91.9 (4.2)</td><td><0.01*</td></tr><tr><td>NHPT: mean (SD) (% unaffected side)</td><td>5.8 (5.9)</td><td>53.1 (23.7)</td>... |
4976c6e49e2e2d21bc85104025c5ae65af0be943790bd64f69426fbb96d76854.png | simple | <table><tr><td></td><td>PFOS</td><td>PFOA</td><td>PFAA sumb</td></tr><tr><td>Testosterone</td><td>−0.087 (−0.32 to 0.15)</td><td>−0.98 (−2.33 to 0.37)</td><td>−0.093 (−0.303 to 0.116)</td></tr><tr><td>lnEstradiol</td><td>−0.001 (−0.008 to 0.005)</td><td>−0.012 (W... | <table><tr><td></td><td>PFOS</td><td>PFOA</td><td>PFAA sumb</td></tr><tr><td>Testosterone</td><td>−0.087 (−0.32 to 0.15)</td><td>−0.98 (−2.33 to 0.37)</td><td>−0.093 (−0.303 to 0.116)</td></tr><tr><td>lnEstradiol</td><td>−0.001 (−0.008 to 0.005)</td><td>−0.012 (−0.051 to 0.027)</td><td>−0.001 (−0.007 to 0.005)</td></tr... | <table><tr><td>lnFAI</td><td>−0.006 (−0.015 to 0.002)</td><td>−0.038 (−0.087 to 0.011)</td><td>−0.006 (−0.014 to 0.001)</td></tr><tr><td>lnTestosterone/LH</td><td>−0.003 (−0.017 to 0.011)</td><td>−0.037 (−0.12 to 0.045)</td><td>−0.003 (−0.016 to 0.009)</td></tr><tr><td>lnFAI/LH</td><td>−0.006 (−0.020 to 0.009)</td><td>... |
3d8f871da57a43c186a601d70c77a4daa66012f68c9aa8d4573bc1665eeee82c.png | simple | <table><tr><td>Characteristics</td><td>Patient 1</td><td>Patient 2</td></tr><tr><td>Age at first visit to fertility clinic</td><td>28 years</td><td>31 years</td></tr><tr><td>Pubarche (spontaneous)</td><td>at 14 years</td><td>at 15 years</td></tr><tr><td>Heights</td><td>170 cm</td><td>156 cm</td></tr><tr><td>Weight</td>... | <table><tr><td>Characteristics</td><td>Patient 1</td><td>Patient 2</td></tr><tr><td>Age at first visit to fertility clinic</td><td>28 years</td><td>31 years</td></tr><tr><td>Pubarche (spontaneous)</td><td>at 14 years</td><td>at 15 years</td></tr><tr><td>Heights</td><td>170 cm</td><td>156 cm</td></tr></table> | <table><tr><td>Characteristics</td><td>Patient 1</td><td>Patient 2</td></tr><tr><td>Weight</td><td>65 kg</td><td>53 kg</td></tr><tr><td>Breast development by Tanner scale</td><td>Stage V</td><td>Stage IV</td></tr><tr><td>Sense of odors</td><td>Normal</td><td>Normal</td></tr><tr><td>Karyotype</td><td>46, XX</td><td>46, ... |
0802ea6f1df5e55f16e802d0e1b76c6863b4cffe9244d323cf23e4d12f4f8f31.png | simple | <table><tr><td>Parameter</td><td>PA (<i>n</i> = 30)</td><td>EH (<i>n</i> = 31)</td><td><i>p</i></td></tr><tr><td>Age (years)</td><td>55 ± 11</td><td>54 ± 10</td><td>NS</td></tr><tr><td>Gender (male/female)</td><td>8/22</td><td>16/14</td><td>NS</td></tr><tr><td>Body mass index (kg/m<sup>2</sup>)</td><td>26.9 &... | <table><tr><td>Parameter</td><td>PA (n = 30)</td><td>EH (n = 31)</td><td>p</td></tr><tr><td>Age (years)</td><td>55 ± 11</td><td>54 ± 10</td><td>NS</td></tr><tr><td>Gender (male/female)</td><td>8/22</td><td>16/14</td><td>NS</td></tr><tr><td>Body mass index (kg/m2)</td><td>26.9 ± 4</td><td>25.1 ± 3</td><td>NS</td></tr><t... | <table><tr><td>Parameter</td><td>PA (n = 30)</td><td>EH (n = 31)</td><td>p</td></tr><tr><td>Metabolic syndrome</td><td>11/30</td><td>8/31</td><td>NS</td></tr><tr><td>Serum K+ (mEq/dL)</td><td>3.99 ± 0.68</td><td>4.27 ± 0.37</td><td><0.05</td></tr><tr><td>Creatinine (mg/dL)</td><td>1 ± 0.19</td><td>0.86 ± 0.15</td><td><... |
131829b4a8382018cd7ec159a10751e254e0966dd6d2d25218c82afb0f3bb596.png | simple | <table><tr><td>2nd AI</td><td>Number of records</td><td>Embryonic mortality rate (%)</td></tr><tr><td>18–29 D</td><td>769,103</td><td>23.00</td></tr><tr><td>30–60 D</td><td>592,243</td><td>21.97</td></tr><tr><td>61–90 D</td><td>462,098</td><td>16.91</td></tr><tr><td>91–140 D</td><td>383,979</td>... | <table><tr><td>2nd AI</td><td>Number of records</td><td>Embryonic mortality rate (%)</td></tr><tr><td>18–29 D</td><td>769,103</td><td>23.00</td></tr><tr><td>30–60 </td><td>592,2</td><td>21</td></tr></table> | <table><tr><td>D</td><td>43</td><td>.97</td></tr><tr><td>61–90 D</td><td>462,098</td><td>16.91</td></tr><tr><td>91–140 D</td><td>383,979</td><td>8.47</td></tr><tr><td>141 D–parturition</td><td>351,455</td><td>3.30</td></tr></table> |
a50071f226715e30a078b1d5b64dd0356a7769d2df346aadf10f9e126291dd1c.png | simple | <table><tr><td>Age</td><td>Gender</td><td>Handedness</td><td>Brain areas with Foci</td></tr><tr><td>38</td><td>Male</td><td>Right</td><td>Right temporal lobe</td></tr><tr><td>54</td><td>Female</td><td>Right</td><td>Left amygdala, left hippocampus, right hippocampus</td></tr><tr><td>42</td><td>Male</td><td>Right</td><td... | <table><tr><td>Age</td><td>Gender</td><td>Handedness</td><td>Brain areas with Foci</td></tr><tr><td>38</td><td>Male</td><td>Right</td><td>Right temporal lobe</td></tr><tr><td>54</td><td>Female</td><td>Right</td><td>Left amygdala, left hippocampus, right hippocampus</td></tr><tr><td>42</td><td>Male</td><td>Right</td><td... | <table><tr><td>21</td><td>Female</td><td>Right</td><td>Left amygdala, left hippocampus</td></tr><tr><td>24</td><td>Female</td><td>Right</td><td>Right amygdala, right hippocampus, right frontal lobe</td></tr><tr><td>23</td><td>Male</td><td>Right</td><td>Right amygdala, right hippocampus</td></tr><tr><td>54</td><td>Femal... |
aaf854461c6a3fc309077acdadbd98dc7f6f62ac7999bf9160114257e40e28ca.png | simple | <table><tr><td>Sampling subjects</td><td>Source of sample</td><td>Number of sample screened</td><td>Positive samples on microbiological analysis</td><td>Positive samples on biochemical analysis</td><td>Genus specific PCR positive</td><td>Serotype identified by multiplex PCR</td></tr><tr><td>Human infants (<5 years)<... | <table><tr><td>Sampling subjects</td><td>Source of sample</td><td>Number of sample screened</td><td>Positive samples on microbiological analysis</td><td>Positive samples on biochemical analysis</td><td>Genus specific PCR positive</td><td>Serotype identified by multiplex PCR</td></tr><tr><td>Human infants (<5 years)</td... | <table><tr><td></td><td></td><td></td><td></td><td>1</td><td></td><td>ella serotypes (n=1)</td></tr><tr><td></td><td>Mint leaves</td><td>20</td><td>0</td><td>0</td><td>0</td><td>ND</td></tr><tr><td>Sewage waste</td><td></td><td>50</td><td>20</td><td>5</td><td>5</td><td>Other Salmonella serotypes (n=5)</td></tr></table> |
126b2fa24cc5798117107415a8847de3e95e14c6f6726c689621b02bb2cfaa20.png | simple | <table><tr><td> </td><td>Waca Playa (Bolivia)</td><td>Pitumarca (Peru)</td></tr><tr><td>Human Development Index</td><td>0.36 <sup>a</sup></td><td>0.51 <sup>b</sup></td></tr><tr><td>Life expectancy (years)</td><td>52.4 <sup>a</sup></td><td>70.0 <sup>b</sup></td></tr><tr><td>National social health security</td><td>SUMI: ... | <table><tr><td></td><td>Waca Playa (Bolivia)</td><td>Pitumarca (Peru)</td></tr><tr><td>Human Development Index</td><td>0.36 a</td><td>0.51 b</td></tr><tr><td>Life expectancy (years)</td><td>52.4 a</td><td>70.0 b</td></tr><tr><td>National social health security</td><td>SUMI: coverage for pregnant women and children unde... | <table><tr><td></td><td>Waca Playa (Bolivia)</td><td>Pitumarca (Peru)</td></tr><tr><td>Distance from community to nearest hospital (km)</td><td>approximately 40 (dirt road) c</td><td>35 (paved road) c</td></tr><tr><td>Beds per inhabitant (number)</td><td>0.66 d</td><td>0.84 e</td></tr></table> |
a39ab10205a0587e1f7ab1f3d69472bc29e841cd9668cda8dce5c582db03952c.png | simple | <table><tr><td>Subpopulation</td><td><i>k</i><sub>o</sub> (h<sup>−1</sup>)</td><td><i>k</i><sub>d</sub> (h<sup>−1</sup>)</td><td><i>k</i><sub>o</sub>/<i>k</i><sub>d</sub></td></tr><tr><td>Virgin females</td><td>0.063 ± 0.003</td><td>0.055 ± 0.003</td><td>1.16</td></tr><tr><td>Virgin males</td><td>... | <table><tr><td>Subpopulation</td><td>ko (h−1)</td><td>kd (h−1)</td><td>ko/kd</td></tr><tr><td>Virgin females</td><td>0.063 ± 0.003</td><td>0.055 ± 0.003</td><td>1.16</td></tr><tr><td>Virgin males</td><td>0.065 ± 0.005</td><td>0.055 ± 0.004</td><td>1.18</td></tr></table> | <table><tr><td>Subpopulation</td><td>ko (h−1)</td><td>kd (h−1)</td><td>ko/kd</td></tr><tr><td>Once-mated females</td><td>0.067 ± 0.004</td><td>0.058 ± 0.004</td><td>1.18</td></tr><tr><td>Once-mated males</td><td>0.062 ± 0.004</td><td>0.053 ± 0.003</td><td>1.18</td></tr><tr><td>Mixed-sex group: females</td><td>0.095 ± 0... |
4c71f8301d11c62ab8c298a8debe73f55e3d1492a7e579a9280cede922178a46.png | simple | <table><tr><td></td><td>Step 1</td><td>Step 2</td><td>Step 3</td><td>Step 4</td><td>Step 5</td><td>Step 6</td><td>Step 7</td></tr><tr><td># Minigaps</td><td>27</td><td>27</td><td>15</td><td>13</td><td>1</td><td>0</td><td>0</td></tr><tr><td>Assembled nt in the big gap</td><td>0</td><td>0</td><td>12,511</td><td>12,511</t... | <table><tr><td></td><td>Step 1</td><td>Step 2</td><td>Step 3</td></tr><tr><td># Minigaps</td><td>27</td><td>27</td><td>15</td></tr><tr><td>Assembled nt in the big gap</td><td>0</td><td>0</td><td>12,511</td></tr><tr><td>Total nt assembled*</td><td>1,808,353</td><td>1,808,353</td><td>1,828,147</td></tr></table> | <table><tr><td>Step 4</td><td>Step 5</td><td>Step 6</td><td>Step 7</td></tr><tr><td>13</td><td>1</td><td>0</td><td>0</td></tr><tr><td>12,511</td><td>12,511</td><td>35,746</td><td>35,746</td></tr><tr><td>1,828,363</td><td>1,832,588</td><td>1,851,716</td><td>1,851,618</td></tr></table> |
9bbc78ccc2c46b50b89e234598edab687c84074c19c1e62641be8e3f80cc8f42.png | simple | <table><tr><td></td><td>Subjects</td><td>Mild</td><td>Moderate</td><td>Severe</td><td>Not related</td><td>Possibly related</td><td>Probably related</td><td>Definitely related</td></tr><tr><td>Overall</td><td>120 (71.9)</td><td>61 (36.5)</td><td>50 (29.9)</td><td>9 (5.4)</td><td>32 (19.2)</td><td>9 (5.4)</td><td>19 (11.... | <table><tr><td></td><td>Subjects</td><td>Mild</td><td>Moderate</td><td>Severe</td><td>Not related</td><td>Possibly related</td><td>Probably related</td><td>Definitely related</td></tr><tr><td>Overall</td><td>120 (71.9)</td><td>61 (36.5)</td><td>50 (29.9)</td><td>9 (5.4)</td><td>32 (19.2)</td><td>9 (5.4)</td><td>19 (11.... | <table><tr><td></td><td>Subjects</td><td>Mild</td><td>Moderate</td><td>Severe</td><td>Not related</td><td>Possibly related</td><td>Probably related</td><td>Definitely related</td></tr><tr><td>Sinusitis</td><td>11 (6.6)</td><td>4 (2.4)</td><td>6 (3.6)</td><td>1 (0.6)</td><td>10 (6.0)</td><td>1 (0.6)</td><td>0</td><td>0<... |
41f9e87ccec817f04562014e21866970569d211e8baf23b38a50e55b498769ad.png | simple | <table><tr><td>Clinical characteristic</td><td>CCR7+ MUC1+</td><td>CCR7+ MUC1-</td><td>CCR7- MUC1+</td><td>CCR7- MUC1-</td><td><i>P value</i></td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td>0.46</td></tr><tr><td> Male</td><td>57/116</td><td>12/116</td><td>17/116</td><td>30/116</td><td></td></tr><tr>... | <table><tr><td>Clinical characteristic</td><td>CCR7+ MUC1+</td><td>CCR7+ MUC1-</td><td>CCR7- MUC1+</td><td>CCR7- MUC1-</td><td>P value</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td>0.46</td></tr><tr><td>Male</td><td>57/116</td><td>12/116</td><td>17/116</td><td>30/116</td><td></td></tr><tr><td>Fema... | <table><tr><td>Clinical characteristic</td><td>CCR7+ MUC1+</td><td>CCR7+ MUC1-</td><td>CCR7- MUC1+</td><td>CCR7- MUC1-</td><td>P value</td></tr><tr><td>Age(year)</td><td></td><td></td><td></td><td></td><td>0.61</td></tr><tr><td>≥50</td><td>52/108</td><td>11/108</td><td>20/108</td><td>25/108</td><td></td></tr><tr><td><5... |
b31fc130dda439a6daf5515dfc30360729a045eea46d138f4f89939e0fbb893d.png | simple | <table><tr><td>Panel</td><td>Criteria</td></tr><tr><td>Professional</td><td>• Be 18 years or older, AND• Live in Australia, Canada, Ireland, New Zealand, United Kingdom or the United States, AND• Have a minimum of 2 years’ experience specialising in research on or treatment of problem gambling.<... | <table><tr><td>Panel</td><td>Criteria</td></tr><tr><td>Professio</td><td>• Be 18 years or older, AND• Live in Australia, Canada, Ireland, New Zealand, United Kingdom or the United States, </td></tr></table> | <table><tr><td>nal</td><td>AND• Have a minimum of 2 years’ experience specialising in research on or treatment of problem gambling.</td></tr><tr><td>Lived experience</td><td>• Be 18 years or older, AND• Live in Australia, Canada, Ireland, New Zealand, United Kingdom or the United States, AND• Have a lived experience of... |
eb67b26ce5be81dd22eeb1fbc8959d925ad217c1eda35ddae7c99323e5e20751.png | complex | <table><tr><td colspan="5">Case study</td></tr><tr><td> </td><td colspan="2">DHp: 9 contacts out of 46</td><td colspan="2">RR: 24 contacts out of 68</td></tr><tr><td> </td><td>Contacts among top 9</td><td>p-value</td><td>Contacts among top 24</td><td>p-value</td></tr><tr><td>MI</td><td>3</td><td>0.2503</td><td>9</td><t... | <table><tr><td colspan="5">Case study</td></tr><tr><td></td><td colspan="2">DHp: 9 contacts out of 46</td><td colspan="2">RR: 24 contacts out of 68</td></tr><tr><td></td><td>Contacts among top 9</td><td>p-value</td><td>Contacts among top 24</td><td>p-value</td></tr></table> | <table><tr><td colspan="5">Case study</td></tr><tr><td>MI</td><td>3</td><td>0.2503</td><td>9</td><td>0.4864929</td></tr><tr><td>MIc</td><td>4</td><td>0.0800</td><td>9</td><td>0.4864929</td></tr></table> |
3a327857ec4455cdb85208db84be2f77ff465656262f9b732b86525e33ee23e1.png | simple | <table><tr><td></td><td>Control</td><td><i>E. coli</i></td><td><i>p</i> value</td><td>Control</td><td><i>S.</i> Typhimurium</td><td><i>p</i> value</td></tr><tr><td>Apical IL-8 concentration</td><td>101.92 ± 4.54</td><td>425.60 ± 20.12</td><td>0.0015</td><td>143.72 ± 16.98</td><td>1129.74 ± 50.37</td... | <table><tr><td></td><td>Control</td><td>E. coli</td><td>p value</td><td>Control</td><td>S. Typhimurium</td><td>p value</td></tr></table> | <table><tr><td>Apical IL-8 concentration</td><td>101.92 ± 4.54</td><td>425.60 ± 20.12</td><td>0.0015</td><td>143.72 ± 16.98</td><td>1129.74 ± 50.37</td><td><0.001</td></tr><tr><td>Basolateral IL-8 concentration</td><td>16.68 ± 2.78</td><td>1188.47 ± 45.02</td><td><0.001</td><td>48.14 ± 14.43</td><td>2516.64 ± 66.17</td... |
72ed6bf244205fe06c04f9ef4546d502cecf382b5299bb600776111432f042c5.png | complex | <table><tr><td>Evaluation</td><td colspan="5">Days after Enrolment</td></tr><tr><td></td><td>0</td><td>3–4</td><td>13–15</td><td>24–32</td><td>84–92</td></tr><tr><td>Notification to study center</td><td>X</td><td></td><td></td><td></td><td></td></tr><tr><td>Entry criteria</td><td>X</td><td></td>... | <table><tr><td>Evaluation</td><td colspan="5">Days after Enrolment</td></tr><tr><td></td><td>0</td><td>3–4</td><td>13–15</td><td>24–32</td><td>84–92</td></tr></table> | <table><tr><td>Notification to study center</td><td>X</td><td></td><td></td><td></td><td></td></tr><tr><td>Entry criteria</td><td>X</td><td></td><td></td><td></td><td></td></tr><tr><td>Written Informed Consent</td><td>X*</td><td>X*</td><td></td><td></td><td></td></tr><tr><td>Demography</td><td>X</td><td></td><td></td><... |
998a7ab8de33fcac39b21ce38502f9b17a10cb278cdfd09bd77d7756851afaa6.png | simple | <table><tr><td>Patient number</td><td>Sex</td><td>Age at diagnosis (years)</td><td>Follow up (years)</td><td>Surfactant disorder</td><td>Mutation</td></tr><tr><td>1*</td><td>M</td><td>0.3</td><td>2.9</td><td>SP-C</td><td>c.424delC</td></tr><tr><td>2*</td><td>M</td><td>0.4</td><td>3.6</td><td>SP-C</td><td>c.566 G > A... | <table><tr><td>Patient number</td><td>Sex</td><td>Age at diagnosis (years)</td><td>Follow up (years)</td><td>Surfactant disorder</td></tr><tr><td>1*</td><td>M</td><td>0.3</td><td>2.9</td><td>SP-C</td></tr><tr><td>2*</td><td>M</td><td>0.4</td><td>3.6</td><td>SP-C</td></tr><tr><td>3*</td><td>F</td><td>0.3</td><td>3.8</td... | <table><tr><td>Mutation</td></tr><tr><td>c.424delC</td></tr><tr><td>c.566 G > A (C189Y)</td></tr><tr><td>c.566 G > A (C189Y)</td></tr><tr><td>c.325-1 G > A</td></tr><tr><td>c.218 T > C (I73T)</td></tr><tr><td>c.218 T > C (I73T)</td></tr><tr><td>c.218 T > C (I73T)</td></tr><tr><td>c.218 T > C (I73T)</td></tr><tr><td>c.2... |
5c4d6bc6f8e3952699e060921f662dd1dd16c1e074f8b7d26acfc47b32c26454.png | complex | <table><tr><td>Molecular function</td><td>GO Name</td><td>Count</td><td>%</td><td><i>P </i>value</td><td>FDR</td></tr><tr><td>GO:0004984</td><td>olfactory receptor activity</td><td>178</td><td>32.07207</td><td>5.862E-158</td><td>8.27E-155</td></tr><tr><td>GO:0034212</td><td>peptide N-acetyltransferase activity</td><td>... | <table><tr><td>Molecular function</td><td>GO Name</td><td>Count</td><td>%</td><td>P value</td><td>FDR</td></tr><tr><td>GO:0004984</td><td>olfactory receptor activity</td><td>178</td><td>32.07207</td><td>5.862E-158</td><td>8.27E-155</td></tr><tr><td>GO:0034212</td><td>peptide N-acetyltransferase activity</td><td>3</td><... | <table><tr><td>Molecular function</td><td>GO Name</td><td>Count</td><td>%</td><td>P value</td><td>FDR</td></tr><tr><td>GO:0016021</td><td>integral to membrane</td><td>289</td><td>52.07207</td><td>1.23979E-32</td><td>1.62E-29</td></tr><tr><td>GO:0031224</td><td>intrinsic to membrane</td><td>293</td><td>52.79279</td><td>... |
293ae19581b00202bd44735fb0fea81918720fec8fe9134c803b471a5cb3b34f.png | simple | <table><tr><td></td><td>Mean+/-SD(nmol/L)</td><td><i>P</i>value</td><td>< 25 nmol/L,% (95%CI)</td><td>< 50 nmol/L,% (95%CI)</td><td>< 75 nmol/L,% (95%CI)</td></tr><tr><td>0-1y stage (infancy)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Total (n = 2116)</td><td>98.7 ± 47.1</td><td></td><t... | <table><tr><td></td><td>Mean+/-SD(nmol/L)</td><td>Pvalue</td><td>< 25 nmol/L,% (95%CI)</td><td>< 50 nmol/L,% (95%CI)</td><td>< 75 nmol/L,% (95%CI)</td></tr><tr><td>0-1y stage (infancy)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Total (n = 2116)</td><td>98.7 ± 47.1</td><td></td><td>0.4 (NC)</td><td>5.... | <table><tr><td></td><td>Mean+/-SD(nmol/L)</td><td>Pvalue</td><td>< 25 nmol/L,% (95%CI)</td><td>< 50 nmol/L,% (95%CI)</td><td>< 75 nmol/L,% (95%CI)</td></tr><tr><td>Male (n = 1221)</td><td>98.5 ± 47.0</td><td></td><td>0.4 (NC)</td><td>5.3 (4.0-6.6)</td><td>34.3 (31.6-37.0)</td></tr><tr><td>Female (n = 895)</td><td>99.1 ... |
777505c5740f8bd50f3c432922e31fd3504c060f8d05d486fb482dddd58de9e0.png | complex | <table><tr><td>Follow up point</td><td>Variables in the equation</td><td>OR (95% CI)</td><td>Nagelkerke<sup>*</sup></td><td>sn/sp</td></tr><tr><td rowspan="2">14 days (n = 235)</td><td>Pain for >30 days in year</td><td>3.2 (1.9 to 5.6)</td><td>0.26</td><td>90/25</td></tr><tr><td>Pain (for every 1 point increase)</td... | <table><tr><td>Follow up point</td><td>Variables in the equation</td><td>OR (95% CI)</td><td>Nagelkerke*</td><td>sn/sp</td></tr><tr><td rowspan="2">14 days (n = 235)</td><td>Pain for >30 days in year</td><td>3.2 (1.9 to 5.6)</td><td>0.26</td><td>90/25</td></tr><tr><td>Pain (for every 1 point increase)</td><td>0.8 (0.8 ... | <table><tr><td rowspan="2">s (n = 150)</td><td>h</td><td>0</td><td></td><td></td></tr><tr><td>1–3 months</td><td>9.3 (3.0 to 29.0)</td><td></td><td></td></tr><tr><td></td><td>>3 months</td><td>3.0(1.3 to 7.0)</td><td></td><td></td></tr></table> |
c0aae4fc09d1214ac974d304eeda73b54bd0bb518bd0b048644c723311aa3280.png | complex | <table><tr><td>Chemistry</td><td>Selection</td><td>Counter-selection</td><td>Targeted or identified targets</td><td>Number of cycles</td><td>Reference</td></tr><tr><td colspan="6"><i>Mammalian Cells</i></td></tr><tr><td>DNA</td><td>YPEN-1</td><td>N9</td><td>Pigpen</td><td>8</td><td>[58]</td></tr><tr><td>DNA</td><td>B l... | <table><tr><td>Chemistry</td><td>Selection</td><td>Counter-selection</td><td>Targeted or identified targets</td><td>Number of cycles</td><td>Reference</td></tr><tr><td colspan="6">Mammalian Cells</td></tr><tr><td>DNA</td><td>YPEN-1</td><td>N9</td><td>Pigpen</td><td>8</td><td>[58]</td></tr><tr><td>DNA</td><td>B lymphoma... | <table><tr><td>DNA</td><td>HEK293T-TLR2-Fc</td><td>No</td><td>TLR2</td><td>7</td><td>[82]</td></tr><tr><td>DNA</td><td>Vaccinia virus-infected HeLa</td><td>Non-infected HeLa</td><td>Hemagglutinin</td><td>20</td><td>[61]</td></tr><tr><td>2′F-Py RNA</td><td>HET-SR-1</td><td>HET-SR</td><td>ND</td><td>10</td><td>[83]</td><... |
5e59ad9104ccdccb787406e45736b41bc8cd7bbc99dfa083923953adc16e63bd.png | complex | <table><tr><td rowspan="2">PRN</td><td colspan="2">PM</td><td colspan="2">MPDR</td></tr><tr><td>Mean (mm)</td><td>Standard Deviation (mm)</td><td>Mean (mm)</td><td>Standard Deviation (mm)</td></tr><tr><td>PRN 3</td><td>10.9</td><td>0.4</td><td>0.01</td><td>0.4</td></tr><tr><td>PRN 6</td><td>3.4</td><td>0.3</td><td>W... | <table><tr><td rowspan="2">PRN</td><td colspan="2">PM</td><td colspan="2">MPDR</td></tr><tr><td>Mean (mm)</td><td>Standard Deviation (mm)</td><td>Mean (mm)</td><td>Standard Deviation (mm)</td></tr><tr><td>PRN 3</td><td>10.9</td><td>0.4</td><td>0.01</td><td>0.4</td></tr><tr><td>PRN 6</td><td>3.4</td><td>0.3</td><td>−0.0... | <table><tr><td>PRN 18</td><td>7.5</td><td>0.3</td><td>−0.01</td><td>0.5</td></tr><tr><td>PRN 21</td><td>1.5</td><td>0.2</td><td>−0.05</td><td>0.5</td></tr><tr><td>PRN 24</td><td>−16.0</td><td>0.3</td><td>0.01</td><td>0.5</td></tr><tr><td>PRN 25</td><td>23.1</td><td>0.5</td><td>−0.03</td><td>0.5</td></tr><tr><td>PRN 29<... |
39b53a535f6856914279a7212ef15faf51efad8fe98f62e9d7796ebe2e164099.png | simple | <table><tr><td>Venue</td><td>Cluster 1 (<i>N</i> = 2715) low-use mean</td><td>Cluster 2 (<i>N</i> = 1236) high-use mean</td><td>Importance (%)</td></tr><tr><td>Sports centre</td><td>1.20</td><td>2.69</td><td>1.00</td></tr><tr><td>Cinema or theatre</td><td>1.35</td><td>2.73</td><td>1.00</td></tr><tr><td>Vending machine<... | <table><tr><td>Venue</td><td>Cluster 1 (N = 2715) low-use mean</td><td>Cluster 2 (N = 1236) high-use mean</td><td>Importance (%)</td></tr><tr><td>Sports centre</td><td>1.20</td><td>2.69</td><td>1.00</td></tr><tr><td>Cinema or theatre</td><td>1.35</td><td>2.73</td><td>1.00</td></tr><tr><td>Vending machine</td><td>1.19</... | <table><tr><td></td><td>1</td><td>4</td><td>0</td></tr><tr><td>A fast food restaurant (KFC, McDonalds)</td><td>1.76</td><td>2.83</td><td>0.99</td></tr><tr><td>A convenience store (7-eleven)</td><td>1.84</td><td>2.99</td><td>0.94</td></tr></table> |
32a8d1a17fd739eff99ba58d21dad99e12ccc9137b85d67c19297fa0ea95de56.png | simple | <table><tr><td></td><td>Group A (<i>n</i> = 31) (Peg-IFNα + RBV + placebo)</td><td>Group B (<i>n</i> = 31) (Peg-IFNα + RBV + Silybin, Vit E, phospholipids)</td><td><i>P</i> Value</td></tr><tr><td>Psychological disorders</td><td>14%</td><td>12%</td><td>NS</td></tr><tr><td>Hypercholesterolemia</td><td>16%</td><... | <table><tr><td></td><td>Group A (n = 31) (Peg-IFNα + RBV + placebo)</td><td>Group B (n = 31) (Peg-IFNα + RBV + Silybin, Vit E, phospholipids)</td></tr><tr><td>Psychological disorders</td><td>14%</td><td>12%</td></tr><tr><td>Hypercholesterolemia</td><td>16%</td><td>32%</td></tr><tr><td>Fatigue</td><td>48%</td><td>44%</t... | <table><tr><td>P Value</td></tr><tr><td>NS</td></tr><tr><td>P < 0.01</td></tr><tr><td>NS</td></tr><tr><td>NS</td></tr><tr><td>P < 0.01</td></tr><tr><td>P < 0.01</td></tr><tr><td>P < 0.01</td></tr><tr><td>P < 0.05</td></tr><tr><td>NS</td></tr><tr><td>P < 0.05</td></tr><tr><td>P < 0.05</td></tr><tr><td>P < 0.05</td></tr>... |
6237d670249a78db45574ea4ba922bfa2b074da3e65c8cb919269be4ef42304d.png | complex | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td><td>Evidence code</td></tr><tr><td rowspan="8"></td><td rowspan="8">Current classification</td><td>Domain <i>Bacteria</i></td><td>TAS [15]</td></tr><tr><td>Phylum <i>Proteobacteria</i></td><td>TAS [16]</td></tr><tr><td>Class <i>Betaproteobacteria</i></td><td>TAS ... | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td><td>Evidence code</td></tr><tr><td rowspan="8"></td><td rowspan="8">Current classification</td><td>Domain Bacteria</td><td>TAS [15]</td></tr><tr><td>Phylum Proteobacteria</td><td>TAS [16]</td></tr><tr><td>Class Betaproteobacteria</td><td>TAS [17,18]</td></tr><tr>... | <table><tr><td></td><td>Salinity</td><td>Non-halophile</td><td>IDA</td></tr><tr><td>MIGS-22</td><td>Oxygen requirement</td><td>Aerobic</td><td>IDA</td></tr><tr><td></td><td>Carbon source</td><td>Varied</td><td>IDA</td></tr><tr><td></td><td>Energy source</td><td>Chemoorganotroph</td><td>NAS</td></tr><tr><td>MIGS-6</td><... |
5828d99561a0db0cf25edff3fb09cb8b3505c8bd455e7e404de4e20a00077ad8.png | simple | <table><tr><td></td><td>HIV+ group only</td><td></td></tr><tr><td>Median Nadir CD4-T+ cells/μL</td><td>198</td><td>IQR: 31-279</td></tr><tr><td>Median current CD4-T+ cells/μL</td><td>597</td><td>IQR: 342-748</td></tr><tr><td>% Plasma undetectable HIV RNA (<50 cp/mL)<sup>1</sup></td><td>95.5%</td><td>-</td>... | <table><tr><td></td><td>HIV+ group only</td><td></td></tr><tr><td>Median Nadir CD4-T+ cells/μL</td><td>198</td><td>IQR: 31-279</td></tr><tr><td>Median current CD4-T+ cells/μL</td><td>597</td><td>IQR: 342-748</td></tr><tr><td>% Plasma undetectable HIV RNA (<50 cp/mL)1</td><td>95.5%</td><td>-</td></tr><tr><td>% CSF Undet... | <table><tr><td>ele carriers</td><td>7.1% (N = 3)</td><td></td></tr><tr><td>% APOE ε2/ε3 allele carriers</td><td>7.1% (N = 3)</td><td>-</td></tr><tr><td>% APOE ε3/ε3 allele carriers</td><td>61.9% (N = 26)</td><td>-</td></tr></table> |
2f91ec4d5d0ac91d100a578f952488ce852698ad97b70fa84149c653a97b4e83.png | complex | <table><tr><td rowspan="2"> </td><td>Switching</td><td>Combination</td><td>Augmentation</td><td>Total</td></tr><tr><td>(N = 133)</td><td>(N = 80)</td><td>(N = 60)</td><td>(N = 273)</td></tr><tr><td>Age (years), mean (95%CI)</td><td>46.5 (44.5-48.4)</td><td>45.9 (43.4-48.1)</td><td>49.0 (46.5-51.4)</td><td>46.8 (45.5-48... | <table><tr><td rowspan="2"></td><td>Switching</td><td>Combination</td><td>Augmentation</td><td>Total</td></tr><tr><td>(N = 133)</td><td>(N = 80)</td><td>(N = 60)</td><td>(N = 273)</td></tr><tr><td>Age (years), mean (95%CI)</td><td>46.5 (44.5-48.4)</td><td>45.9 (43.4-48.1)</td><td>49.0 (46.5-51.4)</td><td>46.8 (45.5-48.... | <table><tr><td rowspan="2"></td><td>Switching</td><td>Combination</td><td>Augmentation</td><td>Total</td></tr><tr><td>(N = 133)</td><td>(N = 80)</td><td>(N = 60)</td><td>(N = 273)</td></tr><tr><td>cation</td><td>1.4)</td><td> (42.5)</td><td>19 (31.7)</td><td>39.6)</td></tr><tr><td>Family structure, n (%)</td><td></td><... |
dfee9ff58682a5caacfd8d543b3af2de6cc4778ce8b7257b42d34d066959b1b7.png | simple | <table><tr><td> </td><td>Important or very important to plan for care</td><td>Have discussed wishes for treatment</td><td>Have discussed unacceptable states of health</td><td>Prepared written advance care plan or living will</td></tr><tr><td>Overall</td><td>76.3%</td><td>51.4%</td><td>46.6%</td><td>16.6%</td></tr><tr><... | <table><tr><td></td><td>Important or very important to plan for care</td></tr><tr><td>Overall</td><td>76.3%</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>69.0%¶</td></tr><tr><td>Female</td><td>82.8%¶</td></tr><tr><td>Age</td><td></td></tr><tr><td>18–34</td><td>75.9%</td></tr><tr><td>35–54</td><td>74.6%</t... | <table><tr><td>Have discussed wishes for treatment</td><td>Have discussed unacceptable states of health</td><td>Prepared written advance care plan or living will</td></tr><tr><td>51.4%</td><td>46.6%</td><td>16.6%</td></tr><tr><td></td><td></td><td></td></tr><tr><td>47.1%†</td><td>46.3%</td><td>15.3%</td></tr><tr><td>55... |
ce48b4ec2da7e425f3f66791bb4e715cbc414208ad0af6787f4def37198cdd08.png | complex | <table><tr><td></td><td></td><td>ALL</td></tr><tr><td></td><td></td><td>(<i>n</i> = 504)</td></tr><tr><td>Age(years)</td><td>Median(IQR)</td><td>71 (59–80)</td></tr><tr><td></td><td><40 yr</td><td>47 (9.3)</td></tr><tr><td></td><td>≧40 yr. <60 yr</td><td>88 (17.5)</td></tr><tr><td></td><td>≧60 y... | <table><tr><td></td></tr><tr><td></td></tr><tr><td>Age(years)</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>Male</td></tr><tr><td rowspan="6">Disease</td></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr><td rowspan="4">Department</td></tr><tr></tr><tr></tr><tr></tr><tr><t... | <table><tr><td></td><td>ALL</td></tr><tr><td></td><td>(n = 504)</td></tr><tr><td>Median(IQR)</td><td>71 (59–80)</td></tr><tr><td><40 yr</td><td>47 (9.3)</td></tr><tr><td>≧40 yr. <60 yr</td><td>88 (17.5)</td></tr><tr><td>≧60 yr. <80 yr</td><td>236 (46.8)</td></tr><tr><td>≧80 yr</td><td>133 (26.4)</td></tr><tr><td></td><... |
5003894356e4bd57978977ebd4bf77eb9f884d1779801bc628df04c3556d3862.png | simple | <table><tr><td>Taxon</td><td>Species</td><td>Isoenzyme</td><td>Sequence identity, %</td></tr><tr><td>Mammals</td><td><i>Homo sapiens - Microcebus murinus</i></td><td>GAPD-1</td><td>91</td></tr><tr><td></td><td><i>Homo sapiens - Callitrix jacchus</i></td><td>GAPD-2</td><td>94</td></tr><tr><td>Teleosts</td><td><i>Tetraod... | <table><tr><td>Taxon</td><td>Species</td><td>Isoenzyme</td><td>Sequence identity, %</td></tr><tr><td>Mammals</td><td>Homo sapiens - Microcebus murinus</td><td>GAPD-1</td><td>91</td></tr><tr><td></td><td>Homo sapiens - Callitrix jacchus</td><td>GAPD-2</td><td>94</td></tr><tr><td>Teleosts</td><td>Tetraodon nigroviridis -... | <table><tr><td></td><td>Tetraodon nigroviridis - Takifugu rubripes</td><td>GAPD-2</td><td>92</td></tr><tr><td>Insects</td><td>Drosophila ananassae - Drosophila virilis</td><td>GAPD</td><td>87</td></tr></table> |
32592d8cd7361d00991bf6f2ce5bf26372c84211ea9b8b7a752fe599e53157e0.png | complex | <table><tr><td>Predictor variable</td><td>Odds Ratio</td><td><i>p</i>-value</td><td>95% Confidence Interval</td></tr><tr><td colspan="4">Health declaration (<i>N</i> = 1459)</td></tr><tr><td> IVQ33/ITQ50: confidence</td><td>0.69</td><td>0.017</td><td>(0.51, 0.94)</td></tr><tr><td colspan="4">Depression coding: IVQ33ITQ... | <table><tr><td>Predictor variable</td><td>Odds Ratio</td><td>p-value</td><td>95% Confidence Interval</td></tr><tr><td colspan="4">Health declaration </td></tr></table> | <table><tr><td colspan="4">(N = 1459)</td></tr><tr><td>IVQ33/ITQ50: confidence</td><td>0.69</td><td>0.017</td><td>(0.51, 0.94)</td></tr><tr><td colspan="4">Depression coding: IVQ33ITQ50 model (N = 1459)</td></tr><tr><td>Non-professional background</td><td>4.39</td><td>0.010</td><td>(1.44, 13.40)</td></tr><tr><td>IVQ33/... |
59f7b3d60a61645c57fb11622a9dc0782922e68ab55f97840fdf2e4a75e1cf96.png | complex | <table><tr><td rowspan="2">Algorithm</td><td rowspan="2">Results </td><td colspan="5">Training </td><td colspan="5">Testing </td></tr><tr><td><i>Gmean</i> (%) </td><td>TN</td><td>FP</td><td>TP</td><td>FN</td><td><i>Gmean</i> (%) </td><td>TN</td><td>FP</td><td>TP</td><td>FN</td></tr><tr><td rowspan="4">RA-PSO</td><td>AV... | <table><tr><td rowspan="2">Algorithm</td><td rowspan="2">Results</td><td colspan="5">Training</td><td colspan="5">Testing</td></tr><tr><td>Gmean (%)</td><td>TN</td><td>FP</td><td>TP</td><td>FN</td><td>Gmean (%)</td><td>TN</td><td>FP</td><td>TP</td><td>FN</td></tr><tr><td rowspan="3">RA-PSO</td><td>AVG</td><td>99.90</td... | <table><tr><td rowspan="2">Algorithm</td><td rowspan="2">Results</td><td colspan="5">Training</td><td colspan="5">Testing</td></tr><tr><td>Gmean (%)</td><td>TN</td><td>FP</td><td>TP</td><td>FN</td><td>Gmean (%)</td><td>TN</td><td>FP</td><td>TP</td><td>FN</td></tr><tr><td>RA-PSO</td><td>STDEV</td><td>1.15</td><td></td><... |
e160d6a60f6a4221953eca88816f1885a85329b849647d390ef4ddab8146e880.png | simple | <table><tr><td>Client Mode</td><td>Indicates</td><td>Server Mode</td><td>Indicates</td></tr><tr><td>INIT</td><td>Initialization.</td><td>INIT</td><td>Initialization.</td></tr><tr><td>SPEAKER</td><td>Client is speaker.</td><td>SPEAKERS_TURN</td><td>Signal creation</td></tr><tr><td>HEARER</td><td>Client is hearer.</td><t... | <table><tr><td>Client Mode</td><td>Indicates</td><td>Server Mode</td><td>Indicates</td></tr><tr><td>INIT</td><td>Initialization.</td><td>INIT</td><td>Initialization.</td></tr><tr><td>SPEAKER</td><td>Client is speaker.</td><td>SPEAKERS_TURN</td><td>Signal creation</td></tr></table> | <table><tr><td>Client Mode</td><td>Indicates</td><td>Server Mode</td><td>Indicates</td></tr><tr><td>HEARER</td><td>Client is hearer.</td><td>HEARERS_TURN</td><td>Signal recognition</td></tr><tr><td>FEEDBACK</td><td>Client is receiving feedback.</td><td>FEEDBACK</td><td>Clients are receiving feedback.</td></tr></table> |
fca01aff07b98f11c61013123e858f5d1b9cb556ab997c05b79c44c72dd024ce.png | complex | <table><tr><td> </td><td>Before treatment</td><td>After treatment</td><td><i>n </i></td><td><i>P </i></td></tr><tr><td colspan="5">Epidermal thickness average (<i>μ</i>m)</td></tr><tr><td>LN</td><td>39.34 (SD 7.83)</td><td>43.37 (SD 9.40)</td><td>16</td><td>0.09</td></tr><tr><td>PS</td><td>38.26 (SD 6.52)</td><td>... | <table><tr><td></td><td>Before treatment</td><td>After treatment</td><td>n</td><td>P</td></tr><tr><td colspan="5">Epidermal thickness average (μm)</td></tr><tr><td>LN</td><td>39.34 (SD 7.83)</td><td>43.37 (SD 9.40)</td><td>16</td><td>0.09</td></tr><tr><td>PS</td><td>38.26 (SD 6.52)</td><td>42.28 (SD 8.24)</td><td>15</t... | <table><tr><td></td><td>Before treatment</td><td>After treatment</td><td>n</td></tr><tr><td>PS</td><td>.55 (DP 11.04)</td><td>58.89 (DP 12.39)</td><td>15</td></tr></table> |
1cee65642409c68e1a47ef2b37dd2fa13fe76f2ad562926c1af0adbbf8ffa54f.png | complex | <table><tr><td rowspan="2">Specimen Source Treatment</td><td rowspan="2">n</td><td colspan="2">MIC Range</td><td rowspan="2">MIC<sub>50</sub> (μg/mL)</td><td rowspan="2">MIC<sub>90</sub> (μg/mL)</td></tr><tr><td>Minimum (μg/mL)</td><td>Maximum (μg/mL)</td></tr><tr><td colspan="6">Urogenital</td></tr... | <table><tr><td rowspan="2">Specimen Source Treatment</td><td rowspan="2">n</td><td colspan="2">MIC Range</td><td rowspan="2">MIC50 (μg/mL)</td><td rowspan="2">MIC90 (μg/mL)</td></tr><tr><td>Minimum (μg/mL)</td><td>Maximum (μg/mL)</td></tr><tr><td colspan="6">Urogenital</td></tr><tr><td>Gepotidacin 1500 mg</td><td>30</t... | <table><tr><td>Gepotidacin 3000 mg</td><td>2</td><td>0.12</td><td>0.25</td><td>...</td><td>...</td></tr><tr><td>Gepotidacin total</td><td>3</td><td>0.12</td><td>0.25</td><td>...</td><td>...</td></tr></table> |
ed2feadd119f80d33edd3171ac4a2d70a8b4a441a66a0fbf5fcffed167e81544.png | complex | <table><tr><td></td><td></td><td colspan="4">Korean sample</td><td colspan="4">STAR*D</td></tr><tr><td>Gene</td><td>Gene full name</td><td colspan="2">SNPs with <i>p</i> < 0.05</td><td>SNPs (tot N)</td><td>Permuted <i>p</i></td><td colspan="2">SNPs with <i>p</i> < 0.05</td><td>SNPs (tot N)</td><td>Permuted <i>p</... | <table><tr><td></td><td></td></tr><tr><td>Gene</td><td>Gene full name</td></tr><tr><td></td><td></td></tr><tr><td>A</td><td></td></tr><tr><td>AGBL1</td><td>ATP/GTP Binding Protein-Like 1</td></tr><tr><td>CYB5A</td><td>Cytochrome B5 Type A (Microsomal)</td></tr><tr><td>MTRF1L</td><td>Mitochondrial Translational Release ... | <table><tr><td colspan="4">Korean sample</td><td colspan="4">STAR*D</td></tr><tr><td colspan="2">SNPs with p < 0.05</td><td>SNPs (tot N)</td><td>Permuted p</td><td colspan="2">SNPs with p < 0.05</td><td>SNPs (tot N)</td><td>Permuted p</td></tr><tr><td>N true</td><td>N false</td><td colspan="2">/</td><td>N true</td><td>... |
3902c29d6c681f5b52376d862882994ff5d148a4d8acecb6249903b54e6882fd.png | simple | <table><tr><td></td><td>Pre-dictive ethics</td><td>Iterative ethics</td></tr><tr><td>1</td><td>Ethical risks are generally predictable</td><td>Ethical risks may NOT be predictable</td></tr><tr><td>2</td><td>Ethical procedures should be pre-specified - Ethics as ‘requirement’</td><td>Ethical procedures shoul... | <table><tr><td></td><td>Pre-dictive ethics</td><td>Iterative ethics</td></tr><tr><td>1</td><td>Ethical risks are generally predictable</td><td>Ethical risks may NOT be predictable</td></tr><tr><td>2</td><td>Ethical procedures should be pre-specified - Ethics as ‘requirement’</td><td>Ethical procedures should be emergen... | <table><tr><td></td><td>rchers</td><td>ers to explore ethical concerns</td></tr><tr><td>6</td><td>Ethics reviews ‘apply’ codes of conduct and treat ethics as a set of ‘accountable standards’</td><td>Ethics reviews analyse ethical concerns with researchers in relation to the specific research context</td></tr><tr><td>7<... |
51cecc689a8dad0523be87c84a660d1e517cf5594e93bbd42a50bebac0d2f485.png | complex | <table><tr><td>Items</td><td>Criteria of remission</td><td>Remitted</td><td>Non-remitted</td><td>Statistics (df)/Cohen’s d</td></tr><tr><td rowspan="3">MMSE Total score</td><td>SWGC*</td><td>26.80 (2.71)</td><td>25.02 (4.42)</td><td>t(110) = 2.576,p = .011/0.485</td></tr><tr><td>PANSS PNS**</td><td>27.33 (2.61)</... | <table><tr><td>Items</td><td>Criteria of remission</td><td>Remitted</td><td>Non-remitted</td><td>Statistics (df)/Cohen’s d</td></tr><tr><td rowspan="3">MMSE Total score</td><td>SWGC*</td><td>26.80 (2.71)</td><td>25.02 (4.42)</td><td>t(110) = 2.576,p = .011/0.485</td></tr><tr><td>PANSS PNS**</td><td>27.33 (2.61)</td><td... | <table><tr><td>Items</td><td>Criteria of remission</td><td>Remitted</td><td>Non-remitted</td><td>Statistics (df)/Cohen’s d</td></tr><tr><td rowspan="3">BACS Verbal FluencyControlled Oral Words ass.test</td><td>SWGC*</td><td>15.05 (3.89)</td><td>14.50 (5.49)</td><td>t(99) = 0.569 p = .571/NA°</td></tr><tr><td>PANSS PNS*... |
4fc3a4f9ecf80d858a929d1290e30af916fab7910088874e22269a360b662c16.png | simple | <table><tr><td>Patient</td><td>Angiographic findings*</td><td>gradient reduction**</td><td>Number of additional Revisions</td><td>Follow up</td></tr><tr><td>1</td><td>HV, PV, SMV occluded</td><td>17 → 8</td><td>2</td><td>2 years</td></tr><tr><td>2</td><td>HV occluded</td><td>30 → 7</td><td>1</td><td>4 years... | <table><tr><td>Patient</td><td>Angiographic findings*</td><td>gradient reduction**</td><td>Number of additional Revisions</td><td>Follow up</td></tr><tr><td>1</td><td>HV, PV, SMV occluded</td><td>17 → 8</td><td>2</td><td>2 years</td></tr><tr><td>2</td><td>HV occluded</td><td>30 → 7</td><td>1</td><td>4 years</td></tr><t... | <table><tr><td>Patient</td><td>Angiographic findings*</td><td>gradient reduction**</td><td>Number of additional Revisions</td><td>Follow up</td></tr><tr><td>4</td><td>HV occluded</td><td>29 → 12</td><td>2</td><td>12 years</td></tr><tr><td>5</td><td>HV occluded</td><td>46 → 6</td><td>1</td><td>5 years</td></tr><tr><td>6... |
8fcf11d824acb1a5a81f8caa09150d6828bcc09d5393c920f817dd05bf2e6985.png | simple | <table><tr><td></td><td>Current</td><td>Desired</td><td>Gap</td><td>Academic Gap</td><td>Community Gap</td></tr><tr><td>Estimating incremental risk incurred by conditional risk factors</td><td>3.84</td><td>4.59</td><td>0.75</td><td>0.83</td><td>0.67</td></tr><tr><td>Estimating cardiovascular risk in primary prevention<... | <table><tr><td></td><td>Current</td><td>Desired</td><td>Gap</td><td>Academic Gap</td><td>Community Gap</td></tr><tr><td>Estimating incremental risk incurred by conditional risk factors</td><td>3.84</td><td>4.59</td><td>0.75</td><td>0.83</td><td>0.67</td></tr><tr><td>Estimating cardiovascular risk in primary prevention<... | <table><tr><td>Identifying major independent cardiovascular risk factors</td><td>4.49</td><td>4.79</td><td>0.30</td><td>0.37</td><td>0.23</td></tr></table> |
09bf4fda8d33e0ae398705d1700edc734c72fc3965e359cd8badfcd343fe5eb3.png | simple | <table><tr><td></td><td>Z</td><td>J</td><td>Milk</td><td>Where</td><td>Store</td><td>Pig</td><td>Past</td><td>Green</td><td>Finish</td><td>Bathroom</td><td>Hungry</td><td>Blue</td></tr><tr><td>Z</td><td>100%</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</t... | <table><tr><td></td><td>Z</td><td>J</td><td>Milk</td><td>Where</td><td>Store</td><td>Pig</td><td>Past</td><td>Green</td><td>Finish</td><td>Bathroom</td><td>Hungry</td><td>Blue</td></tr><tr><td>Z</td><td>100%</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</t... | <table><tr><td>Hungry</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>100%</td><td>-</td></tr><tr><td>Blue</td><td>-</td><td>-</td><td>-</td><td>2%</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>98%</td></tr></table> |
9ec57b6ef0edba41ac28e5e681fbd8046639e0315ad6a1a742c0fdbe6c4e1da7.png | complex | <table><tr><td rowspan="2">Substances</td><td>Retention time</td><td>OLALPZER</td><td>OLALPVIT</td></tr><tr><td>(min)</td><td>Area (%)</td><td>Area (%)</td></tr><tr><td><i>α</i>-Thujene</td><td>12.6</td><td>3.7</td><td>-</td></tr><tr><td><i>α</i>-Pinene</td><td>12.9</td><td>1.7</td><td>10.1</td></tr><tr><td>C... | <table><tr><td rowspan="2">Substances</td><td>Retention time</td><td>OLALPZER</td><td>OLALPVIT</td></tr><tr><td>(min)</td><td>Area (%)</td><td>Area (%)</td></tr><tr><td>α-Thujene</td><td>12.6</td><td>3.7</td><td>-</td></tr><tr><td>α-Pinene</td><td>12.9</td><td>1.7</td><td>10.1</td></tr><tr><td>Camphene</td><td>13.6</td... | <table><tr><td rowspan="2">Substances</td><td>Retention time</td><td>OLALPZER</td><td>OLALPVIT</td></tr><tr><td>(min)</td><td>Area (%)</td><td>Area (%)</td></tr><tr><td>β-Pinene</td><td>14.8</td><td>3.0</td><td>35.3</td></tr><tr><td>β-Myrcene</td><td>15.4</td><td>1.1</td><td>-</td></tr><tr><td>Phellandrene</td><td>16.1... |
af0c9d4830a122941016485cc16a754e888dd7b62bf43f013507b2e99589250a.png | complex | <table><tr><td>Patient</td><td>Age</td><td>First presentation</td><td>Patient interval</td><td>Residential area<sup>a</sup></td><td>Full-time job</td><td>Cohabitant children</td></tr><tr><td colspan="7">Pre-disaster</td></tr><tr><td> 1</td><td>(50–65]</td><td>Apr.-Jun. 2007</td><td>120 months</td><td>Voluntary ev... | <table><tr><td>Patient</td><td>Age</td><td>First presentation</td><td>Patient interval</td><td>Residential areaa</td><td>Full-time job</td><td>Cohabitant children</td></tr><tr><td colspan="7">Pre-disaster</td></tr><tr><td>1</td><td>(50–65]</td><td>Apr.-Jun. 2007</td><td>120 months</td><td>Voluntary evacuation zone</td>... | <table><tr><td>Patient</td><td>Age</td><td>First presentation</td><td>Patient interval</td><td>Residential areaa</td><td>Full-time job</td><td>Cohabitant children</td></tr><tr><td>18</td><td>(50–65]</td><td>Dec. 2015-Feb. 2016</td><td>12 months</td><td>Voluntary evacuation zone</td><td>Yes</td><td>No</td></tr></table> |
57c1d187227f79836e9728f8bf88b636cd7953142369a3e3056e40734767abe9.png | simple | <table><tr><td> </td><td>Treatment group</td><td>Control group</td><td>p-value</td></tr><tr><td>Stage Ib</td><td>15 (1)</td><td>16 (2)</td><td>-</td></tr><tr><td>Stage II</td><td>1</td><td>0</td><td>-</td></tr><tr><td>Total gastrectomy</td><td>4</td><td>3</td><td>-</td></tr><tr><td>Distal gastrectomy</td><td>12 (1)</td... | <table><tr><td></td><td>Treatment group</td><td>Control group</td><td>p-value</td></tr><tr><td>Stage Ib</td><td>15 (1)</td><td>16 (2)</td><td>-</td></tr><tr><td>Stage II</td><td>1</td><td>0</td><td>-</td></tr><tr><td>Total gastrectomy</td><td>4</td><td>3</td><td>-</td></tr><tr><td>Distal gastrectomy</td><td>12 (1)</td>... | <table><tr><td>Age (year, mean ± SD, median)</td><td>53.75±10.25, 54</td><td>54.87±11.51, 52.5</td><td>0.77</td></tr><tr><td>BMI (mean ± SD)</td><td>23.21±2.09</td><td>23.57±1.93</td><td>0.63</td></tr><tr><td>Systolic BP (mmHg, mean ± SD)</td><td>112.88±9.23</td><td>108.88±9.84</td><td>0.24</td></tr><tr><td>Diastolic B... |
9315191684afccbe1f93052fcaabac3c1dae94f26a7c1694f054364dde8be815.png | simple | <table><tr><td>Top</td><td>Regulator</td><td>Out- degree</td><td>Supported by<sup>a</sup></td></tr><tr><td>1</td><td>hsa-miR-590-3p</td><td>320</td><td>-</td></tr><tr><td>2</td><td>hsa-miR-548c-3p</td><td>302</td><td>-</td></tr><tr><td>3</td><td>hsa-miR-570</td><td>243</td><td>-</td></tr><tr><td>4</td><td>hsa-miR-340</... | <table><tr><td>Top</td><td>Regulator</td><td>Out- degree</td><td>Supported bya</td></tr><tr><td>1</td><td>hsa-miR-590-3p</td><td>320</td><td>-</td></tr><tr><td>2</td><td>hsa-miR-548c-3p</td><td>302</td><td>-</td></tr><tr><td>3</td><td>hsa-miR-570</td><td>243</td><td>-</td></tr><tr><td>4</td><td>hsa-miR-340</td><td>242<... | <table><tr><td>Top</td><td>Regulator</td><td>Out- degree</td><td>Supported bya</td></tr><tr><td>6</td><td>JUN</td><td>59</td><td>-</td></tr><tr><td>7</td><td>E2F4</td><td>50</td><td>PMID: 19473719</td></tr><tr><td>8</td><td>HIF1A</td><td>48</td><td>PMID: 22115707</td></tr><tr><td>9</td><td>NFKB1</td><td>48</td><td>-</t... |
dd8c6a91539367d95688a0379370c926124cc282b75588b63dad2b446494cd63.png | complex | <table><tr><td>Sample</td><td>Extent of ageing (weeks)</td><td colspan="4">Difference in colour (aged versus unaged)</td><td colspan="2">Mean tensile properties</td></tr><tr><td> </td><td> </td><td>ΔE<sub>00</sub>*</td><td>ΔL*</td><td>Δa*</td><td>Δb*</td><td>Breaking load (N)</td><td>Extension (%)</... | <table><tr><td>Sample</td><td>Extent of ageing (weeks)</td><td colspan="4">Difference in colour (aged versus unaged)</td><td colspan="2">Mean tensile properties</td></tr><tr><td></td><td></td><td>ΔE00*</td><td>ΔL*</td><td>Δa*</td><td>Δb*</td><td>Breaking load (N)</td><td>Extension (%)</td></tr><tr><td>WU</td><td>0</td>... | <table><tr><td>AU</td><td>0</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td><td>239.9 (43.1)</td><td>3.9 (0.5)</td></tr><tr><td></td><td>1</td><td>2.39</td><td>−2.17</td><td>0.67</td><td>2.78</td><td>255.5 (38.1)</td><td>3.7 (0.5)</td></tr><tr><td></td><td>2</td><td>3.08</td><td>−2.82</td><td>1.05</td><td>3.43<... |
16a5d80965422425dc708e0da6ee3584e90340651f3b3a1b91f6628c54c970c3.png | simple | <table><tr><td>Symptom</td><td><i>n </i></td><td>%</td></tr><tr><td>Bloated stomach </td><td>56</td><td>61.5</td></tr><tr><td>Anemia</td><td>48</td><td>52.7</td></tr><tr><td>Weight loss</td><td>44</td><td>48.3</td></tr><tr><td>Diarrhea</td><td>36</td><td>39.6</td></tr><tr><td>Vomiting</td><td>18</td><td>19.8</td></tr><... | <table><tr><td>Symptom</td><td>n</td><td>%</td></tr><tr><td>Bloated stomach</td><td>56</td><td>61.5</td></tr><tr><td>Anemia</td><td>48</td><td>52.7</td></tr><tr><td>Weight loss</td><td>44</td><td>48.3</td></tr><tr><td>Diarrhea</td><td>36</td><td>39.6</td></tr></table> | <table><tr><td>Symptom</td><td>n</td><td>%</td></tr><tr><td>Vomiting</td><td>18</td><td>19.8</td></tr><tr><td>Other symptoms/signs</td><td>31</td><td>34.1</td></tr></table> |
823527cb17c9a164c03dd2e9f7578f757af57ab5ab14a818c934eea4780cabf0.png | complex | <table><tr><td rowspan="2">Studies</td><td rowspan="2">Number of studies</td><td colspan="2">Heterogeneity test</td><td rowspan="2">Analysis model</td><td rowspan="2">OR (95% CI)</td><td colspan="2">Hypothesis test</td><td colspan="2">Begg's test</td><td colspan="2">Egger's test</td></tr><tr><td><i>Q</i></td><td><i>P</... | <table><tr><td rowspan="2">Studies</td><td rowspan="2">Number of studies</td><td colspan="2">Heterogeneity test</td><td rowspan="2">Analysis model</td><td rowspan="2">OR (95% CI)</td><td colspan="2">Hypothesis test</td><td colspan="2">Begg's test</td><td colspan="2">Egger's test</td></tr><tr><td>Q</td><td>P</td><td>Z</... | <table><tr><td rowspan="2">Studies</td><td rowspan="2">Number of studies</td><td colspan="2">Heterogeneity test</td><td rowspan="2">Analysis model</td><td rowspan="2">OR (95% CI)</td><td colspan="2">Hypothesis test</td><td colspan="2">Begg's test</td><td colspan="2">Egger's test</td></tr><tr><td>Q</td><td>P</td><td>Z</... |
6dc93c8499abb7954793fb7eff5f64abfb2f028ad48c2898a3af814db981832f.png | complex | <table><tr><td colspan="2">Variable</td><td>Non malignant N (%)</td><td>Malignant N (%)</td><td>COR (95% CI)</td><td>AOR (95% CI)</td></tr><tr><td rowspan="2">Sex</td><td>Male</td><td>171(92.4)</td><td>14(7.6)</td><td>1.05(0.56-1.94)</td><td></td></tr><tr><td>Female</td><td>613(92.7)</td><td>48(7.3)</td><td>1</td><td><... | <table><tr><td colspan="2">Variable</td><td>Non malignant N (%)</td><td>Malignant N (%)</td><td>COR (95% CI)</td><td>AOR (95% CI)</td></tr><tr><td rowspan="2">Sex</td><td>Male</td><td>171(92.4)</td><td>14(7.6)</td><td>1.05(0.56-1.94)</td><td></td></tr><tr><td>Female</td><td>613(92.7)</td><td>48(7.3)</td><td>1</td><td><... | <table><tr><td colspan="2">Variable</td><td>Non malignant N (%)</td><td>Malignant N (%)</td><td>COR (95% CI)</td><td>AOR (95% CI)</td></tr><tr><td rowspan="3">Size in cm</td><td>2-2.49</td><td>9(90.0)</td><td>1(10)</td><td>1.41(0.18-11.3)</td><td>02.87(0.22-15.98)</td></tr><tr><td>3-3.5</td><td>6(85.7)</td><td>1(14.3)<... |
662c373d85737f7bc82ec4b06c1b4b24e467f61ebb0eda0dbbd5a1539f40efeb.png | simple | <table><tr><td> </td><td><i>P</i> value</td><td>OR</td><td>95% CI</td></tr><tr><td>Clavicle tunnel position (<i>x</i>-axis)</td><td>.454</td><td>1.19</td><td>0.77–2.00</td></tr><tr><td>Duration (within 5 days)</td><td>.002</td><td>1.82</td><td>1.32–2.87</td></tr><tr><td>Initial reduction (Good)</td><td>.003... | <table><tr><td></td><td>P</td><td>OR</td><td></td></tr></table> | <table><tr><td></td><td> value</td><td></td><td>95% CI</td></tr><tr><td>Clavicle tunnel position (x-axis)</td><td>.454</td><td>1.19</td><td>0.77–2.00</td></tr><tr><td>Duration (within 5 days)</td><td>.002</td><td>1.82</td><td>1.32–2.87</td></tr><tr><td>Initial reduction (Good)</td><td>.003</td><td>59.71</td><td>6.71–18... |
ed6996374addf1cee0f3e84728fc0085689ad72af2043538cfb4cab92a7cda82.png | complex | <table><tr><td>Gene<sup>1</sup></td><td>Gene product<sup>2</sup></td><td>Reference</td></tr><tr><td colspan="3"><underline><i>A: Containing a TTA codon</i></underline></td></tr><tr><td>SCO4262</td><td>Hypothetical protein</td><td>[55]</td></tr><tr><td>SCO6638</td><td>Hypothetical protein</td><td>[55]</td></tr><tr><td c... | <table><tr><td>Gene1</td><td>Gene product2</td><td>Reference</td></tr><tr><td colspan="3">A: Containing a TTA codon</td></tr><tr><td>SCO4262</td><td>Hypothetical protein</td><td>[55]</td></tr><tr><td>SCO6638</td><td>Hypothetical protein</td><td>[55]</td></tr><tr><td colspan="3">B: Regulated by a TTA-containing gene</td... | <table><tr><td>Gene1</td><td>Gene product2</td><td>Reference</td></tr><tr><td>By act II-ORF4</td><td></td><td></td></tr><tr><td>SCO5071</td><td>Hydroxylacyl-CoA dehydrogenase, ActVI-ORFA</td><td>[14]</td></tr><tr><td>SCO5073</td><td>Putative oxidoreductase, ActVI-ORF2</td><td>[14]</td></tr><tr><td>SCO5074</td><td>Putat... |
48e23524a4484d61cd756651603bdda92d50904f7308a8c6778ac6f94cccec98.png | complex | <table><tr><td>Domain</td><td>Question</td><td>Key process probed</td><td>Significance</td></tr><tr><td rowspan="2">Background</td><td>Previous occupation?</td><td>Previous cognitive/auditory function, noise exposure</td><td>Correct interpretation of hearing tests</td></tr><tr><td>Previous level of musical training and... | <table><tr><td>Domain</td><td>Question</td><td>Key process probed</td><td>Significance</td></tr><tr><td rowspan="2">Background</td><td>Previous occupation?</td><td>Previous cognitive/auditory function, noise exposure</td><td>Correct interpretation of hearing tests</td></tr><tr><td>Previous level of musical training and... | <table><tr><td>Domain</td><td>Question</td><td>Key process probed</td><td>Significance</td></tr><tr><td rowspan="2">tection</td><td>V or to ask people to speak louder?</td><td></td><td>use)</td></tr><tr><td>Is there a complaint that increasing volume makes sounds suddenly seem too loud?</td><td>Impaired sound detection... |
ba76932ac4ad64a2fd5dbf3637d7d80215e65fa792dfe490d6a6044f15bc6e9b.png | complex | <table><tr><td rowspan="2">Level of education</td><td rowspan="2">Specialization/means of accessing information</td><td rowspan="2"><i>n</i></td><td>Heard about aflatoxins</td></tr><tr><td>Frequency (% of <i>n</i>)</td></tr><tr><td> </td><td><i>Specialization</i></td><td> </td><td> </td></tr><tr><td rowspan="2">Low</td... | <table><tr><td rowspan="2">Level of education</td><td rowspan="2">Specialization/means of accessing information</td></tr><tr></tr><tr><td></td><td>Specialization</td></tr><tr><td rowspan="2">Low</td><td>Life/social sciences</td></tr><tr><td>None/other fields</td></tr><tr><td rowspan="2">High</td><td>Life/social science... | <table><tr><td rowspan="2">n</td><td>Heard about aflatoxins</td></tr><tr><td>Frequency (% of n)</td></tr><tr><td></td><td></td></tr><tr><td>0</td><td>0 (0)</td></tr><tr><td>110</td><td>12 (11)</td></tr><tr><td>132</td><td>55 (42)</td></tr><tr><td>16</td><td>4 (25)</td></tr><tr><td>258</td><td>71 (28)</td></tr><tr><td><... |
a604a5d79b209a33384ec497c4bdb9c6cc2a48f12e5a21e13733a4004f529746.png | simple | <table><tr><td>Biological process</td><td></td><td>Number of genes affected by FOS*</td></tr><tr><td><i>Mitochondria</i></td><td>Complex I</td><td>27</td></tr><tr><td></td><td>Complex II</td><td>5</td></tr><tr><td></td><td>Complex III</td><td>2</td></tr><tr><td></td><td>Complex IV</td><td>13</td></tr><tr><td></td><td>C... | <table><tr><td>Biological process</td><td></td><td>Number of genes affected by FOS*</td></tr><tr><td>Mitochondria</td><td>Complex I</td><td>27</td></tr><tr><td></td><td>Complex II</td><td>5</td></tr><tr><td></td><td>Complex III</td><td>2</td></tr><tr><td></td><td>Complex IV</td><td>13</td></tr><tr><td></td><td>Com</td>... | <table><tr><td>Biological process</td><td></td><td>Number of genes affected by FOS*</td></tr><tr><td></td><td>plex V</td><td></td></tr><tr><td></td><td>Metabolism and TCA cycle</td><td>53</td></tr><tr><td></td><td>Mitochondrial ribosomes</td><td>33</td></tr><tr><td></td><td>Protein transport</td><td>11</td></tr><tr><td... |
bad1452dc31fb1fa8f05be625eaab848ba4e1b608a09d4d76688f744535226e2.png | simple | <table><tr><td>Beat type</td><td>Number of beats in Test data set</td><td>Number of beats in Training data set</td><td>Possession rate (%)</td></tr><tr><td>Normal</td><td>54516</td><td>5000</td><td>70.2573</td></tr><tr><td>LBBB</td><td>6036</td><td>1000</td><td>7.7746</td></tr><tr><td>RBBB</td><td>5410</td><td>1000</td... | <table><tr><td>Beat type</td></tr><tr><td>Normal</td></tr><tr><td>LBBB</td></tr><tr><td>RBBB</td></tr><tr><td>PVC</td></tr><tr><td>APB</td></tr><tr><td>PB</td></tr><tr><td>Total</td></tr></table> | <table><tr><td>Number of beats in Test data set</td><td>Number of beats in Training data set</td><td>Possession rate (%)</td></tr><tr><td>54516</td><td>5000</td><td>70.2573</td></tr><tr><td>6036</td><td>1000</td><td>7.7746</td></tr><tr><td>5410</td><td>1000</td><td>6.9889</td></tr><tr><td>5293</td><td>1000</td><td>6.81... |
d8ba7e212b1ef408fd5eed815ce6866bcf50bc907e4e616b27b093145a7db640.png | complex | <table><tr><td></td><td colspan="9">Input Text Symbol</td></tr><tr><td>Current State</td><td>A</td><td>B</td><td>C</td><td>D</td><td>E</td><td>F</td><td>...</td><td>Z</td><td>Match</td></tr><tr><td>0</td><td>1</td><td>0</td><td>7</td><td>0</td><td>0</td><td>0</td><td>0,0,...,0</td><td>0</td><td>Ø</td></tr><tr><td>... | <table><tr><td></td><td colspan="9">Input Text Symbol</td></tr><tr><td>Current State</td><td>A</td><td>B</td><td>C</td><td>D</td><td>E</td><td>F</td><td>...</td><td>Z</td><td>Match</td></tr><tr><td>0</td><td>1</td><td>0</td><td>7</td><td>0</td><td>0</td><td>0</td><td>0,0,...,0</td><td>0</td><td>Ø</td></tr></table> | <table><tr><td></td><td colspan="9">Input Text Symbol</td></tr><tr><td>1</td><td>1</td><td>0</td><td>2</td><td>0</td><td>0</td><td>0</td><td>0,0,...,0</td><td>0</td><td>Ø</td></tr><tr><td>2</td><td>3</td><td>0</td><td>7</td><td>0</td><td>6</td><td>0</td><td>0,0,...,0</td><td>0</td><td>Ø</td></tr><tr><td>3</td><td>1</td... |
562bec6e1602bdd3614addbb7e6da38a24f2094e235e0bc69878411eaaac7380.png | complex | <table><tr><td rowspan="2">Patient characteristics</td><td colspan="2">NNStotal</td><td colspan="2">NNS carb.beverages</td><td colspan="2">NNS non-carb.beverages</td><td colspan="2">NNSsweeteners</td></tr><tr><td>B</td><td><i>p</i>-value</td><td>B</td><td><i>p</i>-value</td><td>B</td><td><i>p</i>-value</td><td>B</td><t... | <table><tr><td rowspan="2">Patient characteristics</td><td>NNStotal</td></tr><tr><td>B</td></tr><tr><td>Gender (female/male)</td><td>−0.10</td></tr><tr><td>Age (years)</td><td>−0.04</td></tr><tr><td>BMI (kg/m2)</td><td>−0.025</td></tr><tr><td>Living with someone</td><td>−0.728</td></tr><tr><td>Working</td><td>−0.124</t... | <table><tr><td>NNStotal</td><td colspan="2">NNS carb.beverages</td><td colspan="2">NNS non-carb.beverages</td><td colspan="2">NNSsweeteners</td></tr><tr><td>p-value</td><td>B</td><td>p-value</td><td>B</td><td>p-value</td><td>B</td><td>p-value</td></tr><tr><td>0.838</td><td>0.519</td><td>0.285</td><td>−0.049</td><td>0.9... |
c5437ab8b1c6cc2333c4ecdd89b8e9f7d4b4344a38fa1c4039dc76146c11c1a9.png | complex | <table><tr><td> </td><td> </td><td colspan="4"> <i>Attentional bias index to fearful expression</i> </td></tr><tr><td> </td><td> </td><td> <i>12 months</i> </td><td> <i>18 months</i> </td><td> <i>24 months</i> </td><td> <i>36 months</i> </td></tr><tr><td>Fear scale (IBQ-R or ECBQ)</td><td>12 months</td><td>−.020<... | <table><tr><td></td><td></td><td colspan="4">Attentional bias index to fearful expression</td></tr><tr><td></td><td></td><td>12 months</td><td>18 months</td><td>24 months</td><td>36 months</td></tr><tr><td>Fear scale (IBQ-R or ECBQ)</td><td>12 months</td><td>−.020</td><td>-</td><td>-</td><td>-</td></tr><tr><td></td><td... | <table><tr><td></td><td>24 months</td><td>−.100</td><td>−.335</td><td>−.262</td><td>-</td></tr><tr><td></td><td>36 months</td><td>.174</td><td>−.463</td><td>.105</td><td>.017</td></tr><tr><td>Average score of scales loading on Negative Affect</td><td>12 months</td><td>.527**</td><td>-</td><td>-</td><td>-</td></tr><tr><... |
bb2cbec9f890a58f97fd5167890be8d62b80f7a8e7f9b28cd6c968b4c74e717e.png | simple | <table><tr><td></td><td>Pearls</td><td>Cheese matrix</td></tr><tr><td>Total solids (%)</td><td>79.09</td><td>70.37</td></tr><tr><td>Fat (%)</td><td>28</td><td>32</td></tr><tr><td>FDM (%)</td><td>35.4</td><td>45.5</td></tr><tr><td>Free leucine (%)</td><td>1.0</td><td>–</td></tr></table> | <table><tr><td></td><td>Pearls</td></tr><tr><td>Total solids (%)</td><td>79.09</td></tr><tr><td>Fat (%)</td><td>28</td></tr><tr><td>FDM (%)</td><td>35.4</td></tr><tr><td>Free leucine (%)</td><td>1.0</td></tr></table> | <table><tr><td>Cheese matrix</td></tr><tr><td>70.37</td></tr><tr><td>32</td></tr><tr><td>45.5</td></tr><tr><td>–</td></tr></table> |
2e6c62a5b70d6b6515b98ef8dac3dffa1421f8b3482b5f455ed7cc3a30427622.png | simple | <table><tr><td>Gait speed change DT</td><td><i>P</i></td><td>Stand. β</td><td><i>R</i><sup>2</sup></td><td>95% CI</td></tr><tr><td>SAI mean</td><td><0.001</td><td>−0.46</td><td>0.22</td><td>[−39.0, −13.7]</td></tr><tr><td>Adjusted for age</td><td><0.001</td><td>−0.47</td><td>0.23</td>... | <table><tr><td>Gait</td><td>P</td><td>Stand. </td><td>R</td><td>95% CI</td></tr></table> | <table><tr><td> speed change DT</td><td></td><td>β</td><td>2</td><td></td></tr><tr><td>SAI mean</td><td><0.001</td><td>−0.46</td><td>0.22</td><td>[−39.0, −13.7]</td></tr><tr><td>Adjusted for age</td><td><0.001</td><td>−0.47</td><td>0.23</td><td>[−39.6, −14.3]</td></tr><tr><td>Adjusted for age, MoCA</td><td>0.015</td><t... |
359b059ec95f47fcce3ab60065428822fc75760d7a3ac4b3b78e18db3a77fe0d.png | complex | <table><tr><td rowspan="2">Stud #</td><td rowspan="2">Institution</td><td colspan="2">Parents</td><td colspan="3">Habitat</td></tr><tr><td>Stud #</td><td>Sex</td><td>XXL</td><td>MIN</td><td>QIO</td></tr><tr><td>358</td><td>WOLONG</td><td>Wild</td><td>-</td><td>0</td><td>0</td><td>1.0</td></tr><tr><td rowspan="2">425</t... | <table><tr><td rowspan="2">Stud #</td><td rowspan="2">Institution</td><td colspan="2">Parents</td><td colspan="3">Habitat</td></tr><tr><td>Stud #</td><td>Sex</td><td>XXL</td><td>MIN</td><td>QIO</td></tr></table> | <table><tr><td>358</td><td>WOLONG</td><td>Wild</td><td>-</td><td>0</td><td>0</td><td>1.0</td></tr><tr><td rowspan="2">425</td><td rowspan="2">CHENGDU</td><td>298</td><td>M</td><td>0</td><td>1.0</td><td>0</td></tr><tr><td>314</td><td>F</td><td>0.5</td><td>0</td><td>0.5</td></tr><tr><td rowspan="2">557</td><td rowspan="2... |
8cdae4e4fad02355b879901beb1f533a1ec83b886ca74f6a0cf7e8e3be4f5363.png | complex | <table><tr><td rowspan="2">Variables</td><td>Number of participants</td><td>Candidiasis</td><td>Bacterial vaginosis</td><td>Trichomoniasis</td></tr><tr><td>N (%)</td><td>N (%)</td><td>N (%)</td><td>N (%)</td></tr><tr><td>Age of participants</td><td></td><td></td><td></td><td></td></tr><tr><td><20</td><td>31 (7.6)</t... | <table><tr><td rowspan="2">Variables</td><td>Number of participants</td><td>Candidiasis</td><td>Bacterial vaginosis</td><td>Trichomoniasis</td></tr><tr><td>N (%)</td><td>N (%)</td><td>N (%)</td><td>N (%)</td></tr><tr><td>Age of participants</td><td></td><td></td><td></td><td></td></tr><tr><td><20</td><td>31 (7.6)</td><... | <table><tr><td>Rural</td><td>116 (28.4)</td><td>8 (6.9)</td><td>7 (10.3)***</td><td>4 (3.4)</td></tr><tr><td>Urban</td><td>293 (71.6)</td><td>26 (8.9)*</td><td>5 (1.7)</td><td>4 (1.4)</td></tr><tr><td>Religion</td><td></td><td></td><td></td><td></td></tr><tr><td>Orthodox</td><td>368 (90)</td><td>27 (7.3)</td><td>12 (2.... |
034bc614837d92fc89605ea37dcf71ab7ccba54d59b96120511b91cb0293ba3a.png | simple | <table><tr><td>Name</td><td>Sequences (5'-3')</td><td>Description</td></tr><tr><td>OP-F</td><td>TCTGGAATGGCTGAAGAAGACG</td><td>Forward primer for the actin gene of <i>T. vaginalis</i> in the first stage</td></tr><tr><td>OP-R</td><td>CAGGGTACATCGTATTGGTC</td><td>Reverse primer for the actin gene of <i>T. vaginalis</i> i... | <table><tr><td>Name</td></tr><tr><td>OP-F</td></tr><tr><td>OP-R</td></tr><tr><td>IP-F</td></tr><tr><td>IP-R</td></tr></table> | <table><tr><td>Sequences (5'-3')</td><td>Description</td></tr><tr><td>TCTGGAATGGCTGAAGAAGACG</td><td>Forward primer for the actin gene of T. vaginalis in the first stage</td></tr><tr><td>CAGGGTACATCGTATTGGTC</td><td>Reverse primer for the actin gene of T. vaginalis in the first stage</td></tr><tr><td>CAGACACTCGTTATCG</... |
cd7ed7dd9690925f0e7cc22100af7ddf29336e247de5b92f04a6ec8f6dfd7cad.png | simple | <table><tr><td>Drugs</td><td>Direct Inhibition of HERG K<sup>+</sup> Channel</td><td>Inhibition of HERG K<sup>+</sup> Channel Trafficking</td></tr><tr><td>Phenothiazines</td><td>+</td><td>?</td></tr><tr><td>Pentamidine</td><td>-</td><td>+</td></tr><tr><td>Geldalamicin</td><td>-</td><td>+</td></tr><tr><td>Arsenic Trioxi... | <table><tr><td>Drugs</td><td>Direct Inhibition of HERG K+ Channel</td><td>Inhibition of HERG K+ Channel Trafficking</td></tr><tr><td>Phenothiazines</td><td>+</td><td>?</td></tr><tr><td>Penta</td><td></td><td>+</td></tr></table> | <table><tr><td>midine</td><td>-</td><td></td></tr><tr><td>Geldalamicin</td><td>-</td><td>+</td></tr><tr><td>Arsenic Trioxide</td><td>-</td><td>+</td></tr><tr><td>Fluoxetine, Norfluoxetine</td><td>+</td><td>+</td></tr><tr><td>Ketoconazole</td><td>+</td><td>+</td></tr><tr><td>Digitoxin, Ouabain, Digoxin</td><td>-</td><td... |
35c4fc5ee56fd9a45688b7be2d21c1ec81e9e0735fa655f66ca6fcd5efbe14fe.png | complex | <table><tr><td rowspan="3">Characteristic</td><td colspan="4">Total nut intake (g/day)</td><td colspan="3">Peanut butter intake (g/day)</td></tr><tr><td>0 g/day</td><td>0.1–< 5</td><td>5–< 10</td><td>10 +g/day</td><td>0 g/day</td><td>0.1–< 5</td><td>5 + g/day</td></tr><tr><td>(<i>n</i> = 821)... | <table><tr><td rowspan="3">Characteristic</td><td colspan="4">Total nut intake (g/day)</td><td colspan="3">Peanut butter intake (g/day)</td></tr><tr><td>0 g/day</td><td>0.1–< 5</td><td>5–< 10</td><td>10 +g/day</td><td>0 g/day</td><td>0.1–< 5</td><td>5 + g/day</td></tr><tr><td>(n = 821)</td><td>(n = 735)</td><td>(n = 22... | <table><tr><td rowspan="3">Characteristic</td><td colspan="4">Total nut intake (g/day)</td><td colspan="3">Peanut butter intake (g/day)</td></tr><tr><td>0 g/day</td><td>0.1–< 5</td><td>5–< 10</td><td>10 +g/day</td><td>0 g/day</td><td>0.1–< 5</td><td>5 + g/day</td></tr><tr><td>(n = 821)</td><td>(n = 735)</td><td>(n = 22... |
47a6e301edf395b8d31b72a42ce6cc4d14631d44b0f2c33096684fc83419af2a.png | simple | <table><tr><td>Variant</td><td><i>p-</i>value<sup>a</sup></td><td>Annotation</td></tr><tr><td>rs1800361</td><td>3.01E-04</td><td>nonsynonymous</td></tr><tr><td>rs145497019</td><td>1.20E-05</td><td>nonsynonymous</td></tr><tr><td>rs1800362</td><td>9.71E-06</td><td>nonsynonymous</td></tr><tr><td>rs1800368</td><td>9.71E-06... | <table><tr><td>Variant</td><td>p-valuea</td><td>Annotation</td></tr><tr><td>rs1800361</td><td>3.01E-04</td><td>nonsynonymous</td></tr><tr><td>rs145497019</td><td>1.20E-05</td><td>nonsynonymous</td></tr><tr><td>rs1800362</td><td>9.71E-06</td><td>nonsynonymous</td></tr><tr><td>rs1800368</td><td>9.71E-06</td><td>nonsynony... | <table><tr><td>rs138629441</td><td>5.79E-06</td><td>nonsynonymous</td></tr><tr><td>rs143152201</td><td>3.19E-06</td><td>nonsynonymous</td></tr><tr><td>9:97869388</td><td>2.33E-06</td><td>nonsynonymous</td></tr><tr><td>FANCC</td><td>2.27E-06b</td><td></td></tr><tr><td>9:97887391</td><td>2.27E-06</td><td>nonsynonymous</t... |
bab6b8a0d457a3f626370fecd81f210e5f009b48944d4827ea15d352da9c0c5c.png | simple | <table><tr><td> </td><td>Total</td><td>Blood</td><td>Urine</td><td>Abscess drainage</td><td>Other</td></tr><tr><td>Gram-positive<sup>a</sup></td><td>90</td><td>44</td><td>27</td><td>25</td><td>18</td></tr><tr><td><i>Streptococcus pneumonia</i></td><td>29</td><td>14</td><td>20<sup>b</sup></td><td>0</td><td>5</td></tr><t... | <table><tr><td></td><td>Total</td><td>Blood</td><td>Urine</td><td>Abscess drainage</td></tr><tr><td>Gram-positivea</td><td>90</td><td>44</td><td>27</td><td>25</td></tr><tr><td>Streptococcus pneumonia</td><td>29</td><td>14</td><td>20b</td><td>0</td></tr><tr><td>Alpha hemolytic streptococci</td><td>18</td><td>7</td><td>0... | <table><tr><td>Other</td></tr><tr><td>18</td></tr><tr><td>5</td></tr><tr><td>7</td></tr><tr><td>1</td></tr><tr><td>0</td></tr><tr><td>2</td></tr><tr><td>3</td></tr><tr><td>0</td></tr><tr><td>0</td></tr><tr><td>9</td></tr><tr><td>3</td></tr><tr><td>1</td></tr><tr><td>0</td></tr><tr><td>1</td></tr><tr><td>0</td></tr><tr>... |
0a9749968f72a22242a7f9ff43efcc22074214aefa01f61531ac9ab54a7732c7.png | simple | <table><tr><td>Grade of fibrosis</td><td>Histological changes</td></tr><tr><td>0</td><td>Normal lung</td></tr><tr><td>1</td><td>Minimal fibrous thickening of alveolar/bronchial walls</td></tr><tr><td>2</td><td><i>Intermediary stage between 1 and 3</i></td></tr><tr><td>3</td><td>Moderate thickening of walls without obvi... | <table><tr><td>Grade of fibrosis</td></tr><tr><td>0</td></tr><tr><td>1</td></tr><tr><td>2</td></tr><tr><td>3</td></tr><tr><td>4</td></tr><tr><td>5</td></tr><tr><td>6</td></tr><tr><td>7</td></tr><tr><td>8</td></tr></table> | <table><tr><td>Histological changes</td></tr><tr><td>Normal lung</td></tr><tr><td>Minimal fibrous thickening of alveolar/bronchial walls</td></tr><tr><td>Intermediary stage between 1 and 3</td></tr><tr><td>Moderate thickening of walls without obvious damage to the lung architecture</td></tr><tr><td>Intermediary stage b... |
94a2afd0c8982bbdc04df896bccd78fcd51de67b8914d1dbb4e5bbd782df4ccb.png | complex | <table><tr><td rowspan="2">Cell lines</td><td rowspan="2">Tissue</td><td colspan="2">Bozepinib</td></tr><tr><td>IC<sub>50</sub> (μM)</td><td>TI</td></tr><tr><td>MCF-7<sup>a</sup></td><td>Breast cancer</td><td>0,355 ± 0,011</td><td>5,14</td></tr><tr><td>MDA-MB 231<sup>a</sup></td><td>Breast cancer</td><td>0,16... | <table><tr><td rowspan="2">Cell lines</td></tr><tr></tr><tr><td>MCF-7a</td></tr><tr><td>MDA-MB 231a</td></tr><tr><td>MDA-MB 468</td></tr><tr><td>SKBR-3</td></tr><tr><td>MCF-10Aa</td></tr><tr><td>Caco-2</td></tr><tr><td>T-84</td></tr><tr><td>HT-29</td></tr><tr><td>SW-480</td></tr><tr><td>HCT-116</td></tr><tr><td>CCD-18C... | <table><tr><td rowspan="2">Tissue</td><td colspan="2">Bozepinib</td></tr><tr><td>IC50 (μM)</td><td>TI</td></tr><tr><td>Breast cancer</td><td>0,355 ± 0,011</td><td>5,14</td></tr><tr><td>Breast cancer</td><td>0,166 ± 0,063</td><td>11</td></tr><tr><td>Breast cancer</td><td>0,850 ± 0,003</td><td>2,14</td></tr><tr><td>Breas... |
bddacd52f2324982740f2dfbb091a4b31b7045a925400cb2ce32963b659fbf82.png | complex | <table><tr><td></td><td colspan="3">Dutch intervention group</td><td colspan="3">Dutch control group</td><td colspan="3">Suriname</td><td colspan="3">Indonesia</td></tr><tr><td>Time point</td><td>T = 0</td><td>T = 1</td><td>p (χ<sup>2</sup>)</td><td>T = 0</td><td>T = 1</td><td>p (χ<sup>2</sup>)</td><td>T = 0<... | <table><tr><td></td><td colspan="3">Dutch intervention group</td><td colspan="3">Dutch control group</td><td colspan="3">Suriname</td><td colspan="3">Indonesia</td></tr><tr><td>Time point</td><td>T = 0</td><td>T = 1</td><td>p (χ2)</td><td>T = 0</td><td>T = 1</td><td>p (χ2)</td><td>T = 0</td><td>T = 1</td><td>p (χ2)</td... | <table><tr><td></td><td colspan="3">Dutch intervention group</td><td colspan="3">Dutch control group</td><td colspan="3">Suriname</td><td colspan="3">Indonesia</td></tr><tr><td>Time point</td><td>T = 0</td><td>T = 1</td><td>p (χ2)</td><td>T = 0</td><td>T = 1</td><td>p (χ2)</td><td>T = 0</td><td>T = 1</td><td>p (χ2)</td... |
407e2c470472b273c0c3dbc94bcdef58d7bd7ae22688cbaba3b7bcaedde918ef.png | complex | <table><tr><td rowspan="2">Absolute change in</td><td colspan="4">One-way travel time by automobile to SPH, min</td></tr><tr><td><45 (<i>n</i> = 69)</td><td>45–150 (<i>n</i> = 25)</td><td>150–360 (<i>n</i> = 39)</td><td>>360 (<i>n</i> = 11)</td></tr><tr><td>FEV1 % predicted/year</td><td>−0.9 [&#... | <table><tr><td>Absolute change in</td><td colspan="4">One-way travel time by automobile to SPH, min</td></tr></table> | <table><tr><td>Absolute change in</td><td><45 (n = 69)</td><td>45–150 (n = 25)</td><td>150–360 (n = 39)</td><td>>360 (n = 11)</td></tr><tr><td>FEV1 % predicted/year</td><td>−0.9 [−1.6, 0.1]</td><td>−0.5 [−1.8, 0.8]</td><td>0.1 [−1.0, 1.2]</td><td>−3.1∗ [−5.1, −1.1]</td></tr><tr><td>BMI (kg/m2)/year</td><td>0.0 [−0.1, 0... |
f2364e0e41cb32f317bf36993a63b7f544bbbf3fd262a0ffac4435f9b3420c9c.png | simple | <table><tr><td>Chrom-dataset</td><td>cM</td><td>Nearest Marker</td><td>lodscore</td><td>Chrom-dataset</td><td>cM</td><td>Nearest Marker</td><td>lodscore</td></tr><tr><td>1-1</td><td>102.0</td><td>D1S1665</td><td>1.29</td><td>8-1</td><td>26.0</td><td>D8S1106</td><td>1.59</td></tr><tr><td>1–3</td><td>114.0</td><td>... | <table><tr><td>Chrom-dataset</td><td>cM</td><td>Nearest Marker</td><td>lodscore</td><td>Chrom-dataset</td><td>cM</td><td>Nearest Marker</td><td>lodscore</td></tr><tr><td>1-1</td><td>102.0</td><td>D1S1665</td><td>1.29</td><td>8-1</td><td>26.0</td><td>D8S1106</td><td>1.59</td></tr><tr><td>1–3</td><td>114.0</td><td>D1S551... | <table><tr><td>1–5</td><td>202.0</td><td>D1S518</td><td>1.15</td><td>8-4</td><td>50.4</td><td>D8S136</td><td>1.95</td></tr><tr><td>1–3</td><td>233.0</td><td>D1S2141</td><td>1.13</td><td>9-5</td><td>85.4</td><td>D9S1120</td><td>1.29</td></tr><tr><td>1–4</td><td>233.0</td><td>D1S2141</td><td>1.87</td><td>9-6</td><td>85.4... |
436fa537059cc4b57d084921c6cd9047a833a9cf1d1c8c860b10878e974dbe89.png | complex | <table><tr><td></td><td colspan="3">Respondents agreeing to each statement</td></tr><tr><td></td><td>Women%</td><td>Men%</td><td>p-value*</td></tr><tr><td>There is often violence at parties</td><td>25</td><td>14</td><td>< 0.001</td></tr><tr><td>Property is often destroyed at parties</td><td>43</td><td>39</td><td>0.0... | <table><tr><td></td></tr><tr><td></td></tr><tr><td>There is often violence at parties</td></tr><tr><td>Property is often destroyed at parties</td></tr><tr><td>There are often accidents with physical injury at parties</td></tr><tr><td>I often baby-sit drunk friends</td></tr><tr><td>I feel I can talk to a friend about hi... | <table><tr><td colspan="3">Respondents agreeing to each statement</td></tr><tr><td>Women%</td><td>Men%</td><td>p-value*</td></tr><tr><td>25</td><td>14</td><td>< 0.001</td></tr><tr><td>43</td><td>39</td><td>0.08</td></tr><tr><td>54</td><td>46</td><td>0.008</td></tr><tr><td>80</td><td>83</td><td>0.09</td></tr><tr><td>89<... |
4389427c21e489acfceaa34b3d2ae5b50199cddd15140f90bdd7d7ecc0a4df9c.png | simple | <table><tr><td>Complications and outcomes</td><td>Conventional (<i>n </i>= 40)</td><td>Restrictive (<i>n </i>= 41)</td></tr><tr><td>Total complications</td><td>43</td><td>45</td></tr><tr><td>Cardiovascular complications</td><td></td><td></td></tr><tr><td> Atrial fibrillation</td><td>2 (4.6)</td><td>1 (2.2)</td></tr><tr... | <table><tr><td>Complications and outcomes</td><td>Conventional (n = 40)</td><td>Restrictive (n = 41)</td></tr><tr><td>Total complications</td><td>43</td><td>45</td></tr><tr><td>Cardiovascular complications</td><td></td><td></td></tr><tr><td>Atrial fibrillation</td><td>2 (4.6)</td><td>1 (2.2)</td></tr><tr><td>Hypertensi... | <table><tr><td>Complications and outcomes</td><td>Conventional (n = 40)</td><td>Restrictive (n = 41)</td></tr><tr><td>Renal dysfunction</td><td>1 (2.3)</td><td>0 (0)</td></tr><tr><td>Gastrointestinal dysfunction</td><td>3 (6.9)</td><td>1 (2.2)</td></tr><tr><td>Total</td><td>5</td><td>1</td></tr><tr><td>Total number of ... |
35b79abe3bca8fddfc1e784277c9d0cdaf5994f4e44e3e5cfae2b9dba8023020.png | complex | <table><tr><td>Type of cost</td><td>Identification</td><td colspan="2">Measurement</td><td colspan="2">Valuation</td></tr><tr><td></td><td>Categories</td><td>Costing method</td><td>Sources of data</td><td>Valuation method</td><td>Sources of data</td></tr><tr><td>Recurrent</td><td></td><td></td><td></td><td></td><td></t... | <table><tr><td>Type of cost</td><td>Identification</td><td colspan="2">Measurement</td><td colspan="2">Valuation</td></tr><tr><td></td><td>Categories</td><td>Costing method</td><td>Sources of data</td><td>Valuation method</td><td>Sources of data</td></tr><tr><td>Recurrent</td><td></td><td></td><td></td><td></td><td></t... | <table><tr><td>Type of cost</td><td>Identification</td><td colspan="2">Measurement</td><td colspan="2">Valuation</td></tr><tr><td></td><td>Categories</td><td>Costing method</td><td>Sources of data</td><td>Valuation method</td><td>Sources of data</td></tr><tr><td>Personnel</td><td>Administration and management, clinical... |
1369e61cfa960ba924c5e2d6b2673bb825bb6267a994759c384bc8379aaa46cc.png | simple | <table><tr><td></td><td>No hypotension</td><td>iNIBP</td><td>dNIBP</td><td><i>p</i> value</td></tr><tr><td>The number of cases in which hypotension was detected faster (<i>n</i> (%))</td><td>24</td><td>47 (61.8)</td><td>29 (38.2)</td><td>0.03</td></tr></table> | <table><tr><td></td><td>No hypotens</td><td>iN</td><td>d</td><td>p value</td></tr></table> | <table><tr><td></td><td>ion</td><td>IBP</td><td>NIBP</td><td></td></tr><tr><td>The number of cases in which hypotension was detected faster (n (%))</td><td>24</td><td>47 (61.8)</td><td>29 (38.2)</td><td>0.03</td></tr></table> |
406355fd7b696b01e9a12b31e243c6b0be53388a696e328758e802d26971a06c.png | complex | <table><tr><td></td><td colspan="2">Activity (U/ml)<sup>1</sup></td><td></td><td></td><td></td><td></td></tr><tr><td>Enzymes</td><td>Soluble fraction</td><td>Insoluble fraction</td><td>Percent of activity found in insoluble fraction<sup>2</sup></td><td>Enzyme amount (mg/ml)<sup>3</sup></td><td>Specific activity (U/mg e... | <table><tr><td></td><td colspan="2">Activity (U/ml)1</td><td></td><td></td><td></td><td></td></tr><tr><td>Enzymes</td><td>Soluble fraction</td><td>Insoluble fraction</td><td>Percent of activity found in insoluble fraction2</td><td>Enzyme amount (mg/ml)3</td><td>Specific activity (U/mg enzyme)3</td><td>Specific activity... | <table><tr><td></td><td colspan="2">Activity (U/ml)1</td><td></td><td></td><td></td><td></td></tr><tr><td>Enzymes</td><td>Soluble fraction</td><td>Insoluble fraction</td><td>Percent of activity found in insoluble fraction2</td><td>Enzyme amount (mg/ml)3</td><td>Specific activity (U/mg enzyme)3</td><td>Specific activity... |
5ee9d43d334a578834cb4ce8797e50700b814407945e73dcd9f987b1796b3cd5.png | simple | <table><tr><td> </td><td>Multivariable logistic regression analysis (n = 362)</td></tr><tr><td><i>Sociodemographic factors</i></td><td>aOR (95%-CI)<sup>a</sup></td></tr><tr><td>Age (continuous)</td><td>1.03 (1.00-1.05)</td></tr><tr><td><i>Health-related factors</i></td><td> </td></tr><tr><td>Current smoker</td><td> </t... | <table><tr><td></td></tr><tr><td>Sociodemographic factors</td></tr><tr><td>Age (continuous)</td></tr><tr><td>Health-related factors</td></tr><tr><td>Current smoker</td></tr><tr><td>Yes</td></tr><tr><td>Not anymore</td></tr><tr><td>Never smoked</td></tr><tr><td>Ever had a diagnosed depression/depressive mood</td></tr><t... | <table><tr><td>Multivariable logistic regression analysis (n = 362)</td></tr><tr><td>aOR (95%-CI)a</td></tr><tr><td>1.03 (1.00-1.05)</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>2.31 (1.27-4.23)</td></tr><tr><td>1.13 (0.66-1.95)</td></tr><tr><td>(Reference)</td></tr><tr><td></td></tr><tr><td>1.85 (1.12-3.06)</t... |
f259e2ee15c1d1d9ec6a26a3d481a987ee1cd63cf7ea46f3d116b971cbdeb92f.png | complex | <table><tr><td rowspan="3">Variable</td><td colspan="3">OR (95 % CI)</td></tr><tr><td rowspan="2">Binary</td><td colspan="2">Multinomial</td></tr><tr><td>Overweight</td><td>Obesity</td></tr><tr><td>Age</td><td>1.09 (1.08, 1.11)</td><td>1.08 (1.07, 1.10)</td><td>1.12 (1.10, 1.15)</td></tr><tr><td colspan="4">Marital sta... | <table><tr><td rowspan="3">Variable</td><td colspan="3">OR (95 % CI)</td></tr><tr><td rowspan="2">Binary</td><td colspan="2">Multinomial</td></tr><tr><td>Overweight</td><td>Obesity</td></tr><tr><td>Age</td><td>1.09 (1.08, 1.11)</td><td>1.08 (1.07, 1.10)</td><td>1.12 (1.10, 1.15)</td></tr><tr><td colspan="4">Marital sta... | <table><tr><td colspan="4">Consumption of fried foodf</td></tr><tr><td>1–3×/month</td><td>1.96 (1.30, 2.95)</td><td>1.81 (1.18, 2.77)</td><td>2.44 (1.34, 4.43)</td></tr><tr><td>1–3×/week</td><td>1.69 (1.13, 2.54)</td><td>1.44 (0.94, 2.20)</td><td>2.62 (1.45, 4.73)</td></tr><tr><td>4–6×/week</td><td>2.44 (1.05, 3.96)</t... |
144502df7f4471fc1307ad19179870f343d597750607eb943de70bfe30b98b1e.png | simple | <table><tr><td>UniProt ID</td><td>Species Name</td><td>Protein Name</td><td>e-value</td><td>Similarity</td></tr><tr><td>Q9XKY50</td><td><i>Phytomonas serpens</i></td><td>MURF1</td><td>5.3e<sup>-148</sup></td><td>100.0%</td></tr><tr><td>Q33559</td><td><i>Leishmania tarentolae</i></td><td>MURF1</td><td>2.7e<sup>-109</sup... | <table><tr><td>UniProt ID</td><td>Species Name</td><td>Protein Name</td><td>e-value</td><td>Similarity</td></tr><tr><td>Q9XKY50</td><td>Phytomonas serpens</td><td>MURF1</td><td>5.3e-148</td><td>100.0%</td></tr><tr><td>Q33559</td><td>Leishmania tarentolae</td><td>MURF1</td><td>2.7e-109</td><td>90.9%</td></tr><tr><td>Q8H... | <table><tr><td>UniProt ID</td><td>Species Name</td><td>Protein Name</td><td>e-value</td><td>Similarity</td></tr><tr><td>Q5AGI5</td><td>Candida albicans</td><td>Hypothetical protein</td><td>7.1e-06</td><td>67.9%</td></tr><tr><td>Q8SKS6</td><td>Ancylostoma duodenale</td><td>NAD4</td><td>7.4e-06</td><td>57.3%</td></tr><tr... |
dfdf485b7bf3226b0b3cab2cc1d1f82b2708875a623254ed257c8a5c918f1361.png | complex | <table><tr><td>Algal species</td><td>Molecular technique</td><td>Bacterial phyla</td><td>Country origin</td><td>Reference</td></tr><tr><td colspan="5">CHLOROPHYTA</td></tr><tr><td><i>Bryopsis hypnoides</i></td><td>CLO, FISH</td><td>BA, FI, PR (al, ep, ga)</td><td>Mexico</td><td>Hollants et al. (2011a,b)</td></tr><tr><t... | <table><tr><td>Algal species</td><td>Molecular technique</td><td>Bacterial phyla</td><td>Country origin</td><td>Reference</td></tr><tr><td colspan="5">CHLOROPHYTA</td></tr><tr><td>Bryopsis hypnoides</td><td>CLO, FISH</td><td>BA, FI, PR (al, ep, ga)</td><td>Mexico</td><td>Hollants et al. (2011a,b)</td></tr><tr><td>Bryop... | <table><tr><td>a</td><td> FISH</td><td>FI, PR (al, ep, ga)</td><td>xico</td><td>lants et al. (2011a,b)</td></tr><tr><td>Caulerpa taxifolia</td><td>CLO, RFLP</td><td>BA, PR (al, be, de, ga)</td><td>4 Countries</td><td>Meusnier et al. (2001)</td></tr><tr><td>Chara aspera</td><td>FISH</td><td>AC, BA, PL, PR (al, be, ga)</... |
1db38825baf696e908391d74b3efc42eda555d1b44292af567ae3fff4b21be17.png | complex | <table><tr><td rowspan="2"> </td><td rowspan="2">Type 2 diabetes phenotype A (n = 77)</td><td rowspan="2">Type 2 diabetes phenotype B (n = 45)</td><td>Control group</td><td>ANOVA</td></tr><tr><td>(n = 54)</td><td>p-value</td></tr><tr><td>Age (years)</td><td>60 ± 11</td><td>56 ± 11 <sup>a</sup></td><td>56 ... | <table><tr><td rowspan="2"></td><td rowspan="2">Type 2 diabetes phenotype A (n = 77)</td></tr><tr></tr><tr><td>Age (years)</td><td>60 ± 11</td></tr><tr><td>Male (%)</td><td>65.9</td></tr><tr><td>BMI (kg/m2)</td><td>29.6 ± 6.2</td></tr><tr><td>Waist (cm)</td><td>104 ± 15</td></tr><tr><td>Diabetes duration (years)</td><t... | <table><tr><td rowspan="2">Type 2 diabetes phenotype B (n = 45)</td><td>Control group</td><td>ANOVA</td></tr><tr><td>(n = 54)</td><td>p-value</td></tr><tr><td>56 ± 11 a</td><td>56 ± 14 a</td><td>0.108</td></tr><tr><td>64.6</td><td>57.4 a, b</td><td><0.001</td></tr><tr><td>31.1 ± 4 a</td><td>25.9 ± 3.6 a, b</td><td><0.0... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.